Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription Articles published in J Dermatol Retrieve available abstracts of 565 articles: HTML format

Single Articles

October 2025
1. GOTO Y, Suzuki T, Honda T
   Dupilumab-Induced Psoriasis-Like Eruption With JAK1-STAT3 Activation Successfully Treated With Upadacitinib.
   J Dermatol. 2025 Oct 23. doi: 10.1111/1346-8138.70035.
   PubMed    
   
   
   
2. LU YY, Liu YC, Chiu YW, Lin SF, et al
   Decreased Plasmacytoid Dendritic Cells in Cutaneous Squamous Cell Carcinoma Arising From Subacute Cutaneous Lupus Erythematosus: A Case Report.
   J Dermatol. 2025 Oct 21. doi: 10.1111/1346-8138.70017.
   PubMed     Abstract available
   
   
   
3. YAMAMURA Y, Fujii K, Nakashima C, Usui S, et al
   Advanced Verrucous Malignant Melanoma Arising on the Plantar Arch.
   J Dermatol. 2025 Oct 18. doi: 10.1111/1346-8138.70029.
   PubMed    
   
   
   
4. WATANABE A, Kamata M, Okada Y, Suzuki S, et al
   Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.
   J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70026.
   PubMed    
   
   
   
5. HATCHO Y, Kiniwa Y, Katsuie S, Kitamura S, et al
   Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.
   J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70018.
   PubMed    
   
   
   
6. WEN W, Yang C, Lin Z
   Multiple Cutaneous Cysts in Nevoid Basal Cell Carcinoma Syndrome.
   J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70025.
   PubMed    
   
   
   
7. 
   Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance".
   J Dermatol. 2025 Oct 13. doi: 10.1111/1346-8138.17976.
   PubMed    
   
   
   
8. HAYASHI W, Kinoshita-Ise M, Mizukawa Y, Ohyama M, et al
   Hyperpigmented Drug Eruption Caused by Sanshishi (Gardenia Fruit): A Rare and Potentially Overlooked Skin Manifestation.
   J Dermatol. 2025 Oct 10. doi: 10.1111/1346-8138.70006.
   PubMed    
   
   
   
9. NAKANO E, Kage Y, Ogata D, Yamazaki N, et al
   Real-World Efficacy and Safety of MEK Inhibitor for Patients With Advanced NRAS-Mutant Melanoma: A Single-Center Retrospective Study in Japan.
   J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.70009.
   PubMed     Abstract available
   
   
   
10. PENG G, Abudouwanli A, Sun Q, Tan Y, et al
    Role of Antimicrobial Peptides in the Pathogenesis of Atopic Dermatitis.
    J Dermatol. 2025 Oct 8. doi: 10.1111/1346-8138.17975.
    PubMed     Abstract available
    
    
    
11. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70002.
    PubMed     Abstract available
    
    
    
12. INOUE S, Shojiguchi N, Murayama Y, Koizumi S, et al
    Recycled Skin Grafting for Reconstruction Following Wide Local Excision of Liposarcoma.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70003.
    PubMed    
    
    
    
13. DANIEL MB, Lucia MG, de la Maria Sierra GP, Salvador AS, et al
    The Impact of Cutaneous Lupus Erythematosus on Major Life-Changing Decisions: A Cross-Sectional Study.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70010.
    PubMed     Abstract available
    
    
    
14. OHTSUKA K, Nakazato S, Hiraki T, Horiuchi M, et al
    PAK2-Fused Porocarcinoma In Situ Presenting With a Cutaneous Horn: A Case Report.
    J Dermatol. 2025 Oct 7. doi: 10.1111/1346-8138.70001.
    PubMed    
    
    
    
15. AOKI M, Fujii K, Yonekura K, Nishida H, et al
    Efficacy and Safety of Helical Tomotherapy Combined With Paclitaxel in Cutaneous Angiosarcoma.
    J Dermatol. 2025 Oct 3. doi: 10.1111/1346-8138.17981.
    PubMed     Abstract available
    
    
    
16. MITANI A, Suzuki Y, Yamamura K, Ishii N, et al
    Sudden Death in a Case of Nonbullous Pemphigoid With Immunoglobulin G Anti-120 kDa Linear IgA Bullous Dermatosis Antigen Autoantibodies.
    J Dermatol. 2025 Oct 2. doi: 10.1111/1346-8138.70000.
    PubMed    
    
    
    
17. KUMA Y, Kido-Nakahara M, Kuba-Fuyuno Y, Matsumoto T, et al
    Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological Analysis.
    J Dermatol. 2025;52:1584-1588.
    PubMed     Abstract available
    
    
    
18. ITAMOTO S, Tu WT, Chang CY, Watanabe M, et al
    Oral Statin Therapy in KRT16- and KRT17-Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita).
    J Dermatol. 2025;52:1608-1611.
    PubMed     Abstract available
    
    
    
19. NOZAKI H, Honma M, Kishibe M, Fujita Y, et al
    Serum Anti-Drug Antibodies in Psoriasis Patients Undergoing Biologic Therapy in Real-World Clinical Practice: A Single-Center Retrospective Study.
    J Dermatol. 2025;52:1598-1602.
    PubMed     Abstract available
    
    
    
20. CHEN X, Wang Z, Li X, Liu G, et al
    A Missense Variant Within the Helix Termination Motif of KRT71 Causes Autosomal Dominant Woolly Hair/Hypotrichosis in a Chinese Family.
    J Dermatol. 2025;52:1603-1607.
    PubMed     Abstract available
    
    
    
21. KOGA M, Yoshinaga A, Ehara Y, Tsuge I, et al
    A Retrospective Study of Diffuse Plexiform Neurofibroma With Surgical Intervention in Neurofibromatosis 1.
    J Dermatol. 2025;52:1589-1592.
    PubMed     Abstract available
    
    
    
22. MORIZANE S, Mukai T, Sunagawa K, Hasui KI, et al
    Biologics and Small-Molecule Therapies in Netherton Syndrome: A Comprehensive Review.
    J Dermatol. 2025;52:1483-1493.
    PubMed     Abstract available
    
    
    
23. WANG Y, Gao J, Li F, Li L, et al
    Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort.
    J Dermatol. 2025;52:1527-1535.
    PubMed     Abstract available
    
    
    
24. NAIK H, Balwani M, Colwell HH, Mathias SD, et al
    The Burden of Erythropoietic Protoporphyria (EPP): Results From the EPP Life Impact and Genetic Health Trajectory (LIGHT) Study.
    J Dermatol. 2025;52:1576-1583.
    PubMed     Abstract available
    
    
    
25. ZHANG K, Qiu T, Zhou J, Gong X, et al
    Comparison of Infantile Hemangiomas in Male and Female Infants: A Prospective Study.
    J Dermatol. 2025;52:1555-1560.
    PubMed     Abstract available
    
    
    
26. HUANG Y, Ke C, Chen M
    Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.
    J Dermatol. 2025;52:1561-1569.
    PubMed     Abstract available
    
    
    
27. OHYAMA M, Ito T, Amoh Y, Inui S, et al
    Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version.
    J Dermatol. 2025;52:e876-e907.
    PubMed     Abstract available
    
    
    
28. NATSUGA K, Tsuruta D, Takashima S, Tateishi C, et al
    Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa.
    J Dermatol. 2025;52:1494-1502.
    PubMed     Abstract available
    
    
    September 2025
29. MATSUSHITA T, Nakao M, Kudo K, Nishio J, et al
    GAVE in Systemic Sclerosis: A Japanese Cohort Study Highlighting Links to Diffuse Cutaneous Subtype and Anti-RNAPIII Antibodies.
    J Dermatol. 2025 Sep 30. doi: 10.1111/1346-8138.17980.
    PubMed     Abstract available
    
    
    
30. IRITAS SY, Iritas I
    Ocular Comorbidities in Psoriasis: A Retrospective Study on Dry Eye Syndrome, Keratoconus, and Cataract Development.
    J Dermatol. 2025 Sep 29. doi: 10.1111/1346-8138.17977.
    PubMed     Abstract available
    
    
    
31. ITO H, Iwata Y, Sugiura M, Arima M, et al
    AID Expression in Vulvar SCC Arising From Lichen Sclerosus et Atrophicus: A Retrospective Study.
    J Dermatol. 2025 Sep 26. doi: 10.1111/1346-8138.17935.
    PubMed     Abstract available
    
    
    
32. LIU G, Huang T, Gao XJ, Ding RL, et al
    Expression of Co-Inhibitory Molecules on Lymphocytes of Patients With Psoriasis.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17937.
    PubMed     Abstract available
    
    
    
33. 
    WITHDRAWAL: Autoimmune Progesterone Dermatitis Treated With Dienogest: A Case Report.
    J Dermatol. 2025 Sep 24. doi: 10.1111/1346-8138.17963.
    PubMed     Abstract available
    
    
    
34. KAMIYA K, Yamaguchi Y, Saeki H, Kodera M, et al
    Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics.
    J Dermatol. 2025 Sep 19. doi: 10.1111/1346-8138.17968.
    PubMed     Abstract available
    
    
    
35. MUTO Y, Fujihara M, Ogawa Y, Oishi N, et al
    Case of Primary Cutaneous Gamma-Delta T-Cell Lymphoma in Which Brentuximab Vedotin-Based Polychemotherapy Failed to Achieve Durable Remission.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17967.
    PubMed    
    
    
    
36. TAKAHASHI Y, Hagino T, Saeki H, Fujimoto E, et al
    A 104-Week Real-World Outcome of Bimekizumab Treatment for Psoriasis: Biologic-Naive Versus -Experienced Patients.
    J Dermatol. 2025 Sep 18. doi: 10.1111/1346-8138.17962.
    PubMed     Abstract available
    
    
    
37. MATSUOKA K, Nakamura Y, Miki H, Nomura T, et al
    Cutaneous Metaplastic Synovial Cyst With Immunohistochemical Studies for Synovial Cell Markers: A Case Report.
    J Dermatol. 2025 Sep 17. doi: 10.1111/1346-8138.17969.
    PubMed    
    
    
    
38. KATO K, Kato H, Magara T, Morita A, et al
    Postoperative Complications and Risk Factors in Skin Tumor Excision With Simple Suturing Under Local Anesthesia: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17958.
    PubMed     Abstract available
    
    
    
39. YAMADA K, Imanishi H, Mine M, Kunimoto H, et al
    Establishment of a Nail Psoriasis Mouse Model by Topical Application of Imiquimod After Nail Removal.
    J Dermatol. 2025 Sep 15. doi: 10.1111/1346-8138.17956.
    PubMed     Abstract available
    
    
    
40. ZHOU W, Cao Y, Wu C, Zhou K, et al
    Should Be Removed or Taken Biopsy in Early Stage: A Retrospective Study of 953 Cases of Nevus Sebaceous From a Single Center.
    J Dermatol. 2025 Sep 10. doi: 10.1111/1346-8138.17941.
    PubMed     Abstract available
    
    
    
41. 
    Correction to "A Case of Metastasis of Giant Basal Cell Carcinoma in Oculocutaneous Albinism".
    J Dermatol. 2025 Sep 9. doi: 10.1111/1346-8138.17955.
    PubMed    
    
    
    
42. TAKAMURA S, Saito S, Sugai S, Shiko Y, et al
    Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17950.
    PubMed     Abstract available
    
    
    
43. DEKIO I, Katsuta M, Ishiuji Y, Nobeyama Y, et al
    Discontinuation Reasons and Drug Survival of Dupilumab in Real-World Adult Atopic Dermatitis Patients in Three Healthcare Facilities in Tokyo and Yokohama (2018-2023).
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17927.
    PubMed     Abstract available
    
    
    
44. AHN HK, Oh S, Yoon HS
    Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy.
    J Dermatol. 2025 Sep 8. doi: 10.1111/1346-8138.17949.
    PubMed     Abstract available
    
    
    
45. ZHANG Y, Cheng C, Xu Z, Yang D, et al
    Indole-3-Lactic Acid Inhibits Keratinocyte Proliferation Through the Aryl Hydrocarbon Receptor in Psoriasis.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17947.
    PubMed     Abstract available
    
    
    
46. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
    Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy.
    J Dermatol. 2025 Sep 5. doi: 10.1111/1346-8138.17938.
    PubMed     Abstract available
    
    
    
47. KIM DH, Kim YJ, Moon IJ, Lee WJ, et al
    The Association Between Melanoma and Autoimmune Diseases: A Nationwide Population-Based Study in the Republic of Korea.
    J Dermatol. 2025 Sep 4. doi: 10.1111/1346-8138.17945.
    PubMed     Abstract available
    
    
    
48. KUDO M, Shirato R, Yanagi T, Yamagata W, et al
    Brain Metastasis From Angiosarcoma of the Scalp: Report of Three Cases.
    J Dermatol. 2025;52:1456-1460.
    PubMed     Abstract available
    
    
    
49. ENDO K, Higaki Y, Cho A, Sugimoto Y, et al
    Disease Impact and Burden of Psoriasis Vulgaris in Visible Body Areas in Japan: A Qualitative Study.
    J Dermatol. 2025;52:1439-1446.
    PubMed     Abstract available
    
    
    
50. MATSUO M, Asahina R, Tawada C, Tanaka K, et al
    A Case of Local Relapse of Pemphigus Vegetans Detected IL-17A(+) Tissue-Resident Memory T Cells in Lesional Skin.
    J Dermatol. 2025;52:1452-1455.
    PubMed     Abstract available
    
    
    
51. WANG QX, He HY, Niu YL, Fang S, et al
    Tofacitinib for the Treatment of Primary Localized Cutaneous Amyloidosis.
    J Dermatol. 2025;52:1461-1464.
    PubMed     Abstract available
    
    
    
52. SUZUKI Y, Tanahashi K, Kobayashi Y, Kinoshita F, et al
    A Cross-Sectional Questionnaire Survey on the Impact of Congenital Ichthyosis on Lifelong Education and Career.
    J Dermatol. 2025;52:1470-1474.
    PubMed     Abstract available
    
    
    
53. BRUCKNER AL, Murrell D, Lee LW, Sprecher E, et al
    Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa-Impact of Oleogel-S10.
    J Dermatol. 2025;52:1447-1451.
    PubMed     Abstract available
    
    
    
54. MATSUSHITA S, Kajihara I, Tsutsui K, Hirai I, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Extramammary Paget Disease 2025.
    J Dermatol. 2025;52:e795-e814.
    PubMed     Abstract available
    
    
    
55. XUE S, He Y, Pei L, Xu H, et al
    Progress of Biologics and Small Molecule Drugs in the Treatment of Hidradenitis Suppurativa.
    J Dermatol. 2025;52:1337-1350.
    PubMed     Abstract available
    
    
    
56. MATSUNAGA-NAKASHIMA H, Sawamura S, Myangat TM, Yamamoto T, et al
    Circulating Interleukin-6 and Janus Kinase 2 DNA Copies in Serum Cell-Free DNA Are Elevated in Patients With Systemic Sclerosis.
    J Dermatol. 2025;52:1430-1438.
    PubMed     Abstract available
    
    
    
57. KANNO K, Kishibe M, Honma M, Ishida-Yamamoto A, et al
    Pathogenesis of Pseudocheckerboard Pattern in Mechanic's Hands.
    J Dermatol. 2025;52:1418-1423.
    PubMed     Abstract available
    
    
    
58. MOTEGI SI, Uchida-Yamada M, Shima Y, Shimada T, et al
    The Prevalence and Severity of Pain in Patients With Systemic Sclerosis.
    J Dermatol. 2025;52:1382-1394.
    PubMed     Abstract available
    
    
    
59. OHYAMA M, Irisawa R, Uchiyama M, Mori M, et al
    Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open-Label Single-Arm Clinical Trial.
    J Dermatol. 2025;52:1351-1359.
    PubMed     Abstract available
    
    
    
60. LI POMI F, d'Aloja A, Rottura M, Vaccaro M, et al
    Tirbanibulin 1% Ointment for the Treatment of Hyperkeratotic Actinic Keratosis.
    J Dermatol. 2025;52:1395-1403.
    PubMed     Abstract available
    
    
    
61. FUJIWARA H, Irisawa R, Otsuka M, Kako T, et al
    Wound, Pressure Ulcer, and Burn Guidelines (2023)-2: Guidelines for the Diagnosis and Treatment of Pressure Ulcers, Third Edition.
    J Dermatol. 2025;52:e744-e794.
    PubMed     Abstract available
    
    
    August 2025
62. FUJIWARA M, Oda A, Ohtake R, Namiki T, et al
    Hydroxychloroquine-Induced Generalized Pustular Psoriasis Successfully Treated With Secukinumab: A Case Report.
    J Dermatol. 2025 Aug 29. doi: 10.1111/1346-8138.17936.
    PubMed    
    
    
    
63. MATSUMURA R, Fukuchi K, Honda T
    Multiple Lichen Striatus Accompanied by Cytomegalovirus Infection.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17934.
    PubMed    
    
    
    
64. ABE M, Igarashi A, Kitajima H, Toyama H, et al
    Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis.
    J Dermatol. 2025 Aug 27. doi: 10.1111/1346-8138.17915.
    PubMed     Abstract available
    
    
    
65. MARTINS F, Mano F
    Primary Cutaneous Endometriosis of the Umbilicus.
    J Dermatol. 2025 Aug 23. doi: 10.1111/1346-8138.17925.
    PubMed    
    
    
    
66. AOKI A, Hatamiya Y, Fukamatsu H, Sugiyama S, et al
    Panton-Valentine Leukocidin-Producing Community-Acquired Methicillin-Resistant Staphylococcus aureus in Skin and Soft Tissue Infections: Clinical and Epidemiological Insights From Japan.
    J Dermatol. 2025 Aug 23. doi: 10.1111/1346-8138.17920.
    PubMed     Abstract available
    
    
    
67. ITO K, Yoshida A, Kishi A, Yamamoto G, et al
    A Case of Necrobiotic Xanthogranuloma Undergone Several Systemic Treatments for Multiple Myeloma: Follow-Up Report of "Necrobiotic Xanthogranuloma With Paraproteinemia Successfully Treated With Melphalan, Prednisolone and Skin Graft".
    J Dermatol. 2025 Aug 21. doi: 10.1111/1346-8138.17922.
    PubMed    
    
    
    
68. KAWAI K, Uchida Y, Kanekura T
    Prognostic Significance of TBX21 and GATA3 Subtype Classification in Indolent Adult T-Cell Leukemia-Lymphoma With Cutaneous Lesions.
    J Dermatol. 2025 Aug 20. doi: 10.1111/1346-8138.17917.
    PubMed     Abstract available
    
    
    
69. MATSUI Y, Kato J, Hida T, Horimoto K, et al
    Extended-Interval Dosing of an Immune Checkpoint Inhibitor Following a Complete Response in Melanoma: A Case Report.
    J Dermatol. 2025 Aug 20. doi: 10.1111/1346-8138.17899.
    PubMed    
    
    
    
70. MATSUMURA R, Kageyama R, Kageyama H, Shimauchi T, et al
    Ulcerative Sarcoidosis With Cutaneous Sarcoid Granulomatous Vasculitis Successfully Treated by Combination Therapy of Tranilast and Roxithromycin.
    J Dermatol. 2025 Aug 15. doi: 10.1111/1346-8138.17916.
    PubMed    
    
    
    
71. HE J, Weng T, Bai J, Zhu W, et al
    Nail Lichen Planus in 81 Patients: A Retrospective Study of Clinical Characteristics, Histopathological Features, and Long-Term Treatment Outcomes.
    J Dermatol. 2025 Aug 14. doi: 10.1111/1346-8138.17907.
    PubMed     Abstract available
    
    
    
72. MATSUMOTO M, Matsudate Y, Kuroo Y, Okazaki H, et al
    A Case of Superimposed Linear Psoriasis That Was Successfully Treated With Secukinumab.
    J Dermatol. 2025 Aug 12. doi: 10.1111/1346-8138.17910.
    PubMed    
    
    
    
73. GERDES S, Weisenseel P, Gross D, Ostendorf R, et al
    Long-Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G-EPOSS Study.
    J Dermatol. 2025 Aug 9. doi: 10.1111/1346-8138.17866.
    PubMed     Abstract available
    
    
    
74. KAKURAI M, Akashi T, Moriyama Y
    Spontaneous Regression of Cutaneous Angiosarcoma: A Case Report.
    J Dermatol. 2025 Aug 8. doi: 10.1111/1346-8138.17903.
    PubMed    
    
    
    
75. HANAMI Y, Nakamura T, Irie K, Mishima H, et al
    Familial Cases of Aicardi-Goutieres Syndrome Presenting With Cutaneous Manifestations of Facial Lipodystrophy and Puffy Digits.
    J Dermatol. 2025 Aug 7. doi: 10.1111/1346-8138.17898.
    PubMed    
    
    
    
76. KASHANI AN, Yazdanparast T, Amiri F, Kashani MN, et al
    Biophysical and Ultrasonographic Findings of Cutaneous Macular Amyloidosis Lesions in Comparison With Uninvolved Skin.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17824.
    PubMed     Abstract available
    
    
    
77. NOGAMI K, Nishikawa Y, Mochida K, Terada T, et al
    Maximum Standard Uptake Value of Pre-Therapeutic (18)F-Fluorodeoxyglucose Positron Emission Tomography Predicts Outcomes in Indolent Adult T-Cell Leukemia/Lymphoma Patients With Cutaneous Involvement.
    J Dermatol. 2025 Aug 6. doi: 10.1111/1346-8138.17867.
    PubMed     Abstract available
    
    
    
78. AZUMA S, Inaba Y, Tateishi C, Hashimoto T, et al
    A Case of Granular C3 Dermatosis With Methemoglobinemia After Administration of Dapsone.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17887.
    PubMed    
    
    
    
79. MATSUO M, Takagi H, Iwata H
    A Case of Atopic Dermatitis Accompanied by Prurigo Nodularis Developed Eosinophilic Pneumonia on Dupilumab Therapy.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17892.
    PubMed    
    
    
    
80. ZHU K, Lu Z, Cao L, Wu P, et al
    Relationships Between Secukinumab Concentrations, Disease Activity, and IL-17A Levels in Psoriasis: A Cross-Sectional Observational Study.
    J Dermatol. 2025 Aug 5. doi: 10.1111/1346-8138.17893.
    PubMed     Abstract available
    
    
    
81. KIM MJ, Kim BR, Lee KH, Ju HJ, et al
    Exploration of Drugs Associated With the Development of Bullous Pemphigoid: A Nationwide Study.
    J Dermatol. 2025;52:1304-1313.
    PubMed     Abstract available
    
    
    
82. SAITO N, Kamei K, Gautier G, Kurosky SK, et al
    Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan.
    J Dermatol. 2025;52:1255-1262.
    PubMed     Abstract available
    
    
    
83. HU X, Liu L, Huang Y, Zhang Y, et al
    Novel Molecular Subtyping Revealed Molecular Pathways That Contribute to the Pathogenesis of Rosacea.
    J Dermatol. 2025;52:1285-1296.
    PubMed     Abstract available
    
    
    
84. HARVEY LF, Kingston P, Kikuchi R, Manasyan A, et al
    Do female patients see their physicians differently? A population-based study evaluating perception of physician communication by patients with hidradenitis suppurativa.
    J Dermatol. 2025;52:1263-1273.
    PubMed     Abstract available
    
    
    
85. YANG MC, Tu WT, Hong YK, Lin YC, et al
    Missense and Inframe Pathogenic Variants in PLEC Lead to Minimal or Delayed-Onset Muscular Dystrophy in Autosomal Recessive Epidermolysis Bullosa Simplex: A Genotype-Phenotype Correlation in Nine Cases.
    J Dermatol. 2025;52:1274-1284.
    PubMed     Abstract available
    
    
    
86. LEE J, Lee JS, Kim JY, Bae JM, et al
    Dermoscopic Features and Their Association With Breslow Thickness of Facial Lentigo Maligna in Koreans: A Multi-Center Retrospective Study.
    J Dermatol. 2025;52:1243-1254.
    PubMed     Abstract available
    
    
    
87. NAKAYAMA Y, Kiyohara E, Nojima S, Fujimoto M, et al
    Primary Cutaneous Peripheral T-Cell Lymphoma, Not Otherwise Specified With a T-Follicular Helper Phenotype Treated by Rituximab and Low-Dose Prednisolone: A Case Report.
    J Dermatol. 2025 Aug 1. doi: 10.1111/1346-8138.17890.
    PubMed    
    
    
    July 2025
88. SOTO-MORENO A, Olivares-Guerrero M, Lopez-Delgado D, Arias-Santiago S, et al
    PTEN Hamartoma Tumor Syndrome/Cowden Syndrome With Diffuse Sebaceous Gland Hyperplasia: Description of an Atypical Phenotype and a Previously Undescribed Pathogenic Variant.
    J Dermatol. 2025 Jul 25. doi: 10.1111/1346-8138.17880.
    PubMed    
    
    
    
89. KAMIYA K, Okubo Y, Tada Y, Saeki H, et al
    Questionnaire Survey on the Treatment of Psoriasis Patients Who Achieved Remission With Biologics.
    J Dermatol. 2025 Jul 25. doi: 10.1111/1346-8138.17871.
    PubMed     Abstract available
    
    
    
90. MATSUZAKI Y, Uehara J, Shibahara T, Suzuki K, et al
    A Case of Metastatic Pigmented Basal Cell Carcinoma With Low Tumor Mutation Burden Responding to Nivolumab.
    J Dermatol. 2025 Jul 24. doi: 10.1111/1346-8138.17881.
    PubMed    
    
    
    
91. SASAKI W, Saito R, Suzuki K, Watanabe D, et al
    Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.
    J Dermatol. 2025 Jul 23. doi: 10.1111/1346-8138.17877.
    PubMed     Abstract available
    
    
    
92. TAKAMURA S, Sugai S, Fukuda T
    Long-Term Clinical Courses and Stratified Management of Dupilumab-Associated Inflammatory Arthritis in Atopic Dermatitis: Two Japanese Cases With Over 200 Weeks of Follow-Up and Musculoskeletal Ultrasound Assessment.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17873.
    PubMed    
    
    
    
93. MATSUI Y, Nakano E, Ogata D, Yamazaki N, et al
    Response to Imatinib in Metastatic Esophageal Melanoma Harboring a KIT L576P (Exon 11) Mutation After Treatment Failure of Immune Checkpoint Inhibitors: A Case Report.
    J Dermatol. 2025 Jul 22. doi: 10.1111/1346-8138.17875.
    PubMed    
    
    
    
94. OIKAWA A, Natsuga K, Watanabe M, Matsukawa T, et al
    Dermoscopic Rosettes in Cutaneous Chronic Graft-Versus-Host Disease.
    J Dermatol. 2025 Jul 21. doi: 10.1111/1346-8138.17870.
    PubMed    
    
    
    
95. IKOMA T, Amagata Y, Fujii K, Aoki M, et al
    Outcomes of Free Tarsoconjunctival Grafts in Lower Eyelid Reconstruction Following Basal Cell Carcinoma Surgery.
    J Dermatol. 2025 Jul 21. doi: 10.1111/1346-8138.17872.
    PubMed     Abstract available
    
    
    
96. FUJISAWA Y, Yoshioka Y, Yoshino K, Fujimura T, et al
    Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025.
    J Dermatol. 2025 Jul 19. doi: 10.1111/1346-8138.17856.
    PubMed     Abstract available
    
    
    
97. ROGGO A, Wuest Y, Dummer R, Ramelyte E, et al
    Pruritus Is an Indicator for Quality of Life in Cutaneous T-Cell Lymphoma.
    J Dermatol. 2025 Jul 18. doi: 10.1111/1346-8138.17847.
    PubMed     Abstract available
    
    
    
98. ZHANG J, Ding Y, Wang P, Li L, et al
    Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Psoriasis: Improvements in Patient-Reported Outcomes in a Randomized Trial.
    J Dermatol. 2025 Jul 17. doi: 10.1111/1346-8138.17834.
    PubMed     Abstract available
    
    
    
99. KIMURA H, Hasegawa A, Kawai T, Ogawa K, et al
    Iatrogenic Kaposi's Sarcoma in a Patient With Chronic Kidney Disease.
    J Dermatol. 2025 Jul 15. doi: 10.1111/1346-8138.17862.
    PubMed    
    
    
    
100. MATSUDA I, Kato J, Fujie C, Horimoto K, et al
     Acral Melanoma Successfully Treated With Dacarbazine Following Anti-PD-1 Antibody Therapy: A Case Report and Literature Review.
     J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17861.
     PubMed    
     
     
     
101. KIMURA H, Oginezawa M, Hama N, Watanabe Y, et al
     Efficacy and Safety of Etanercept in Japanese Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Unresponsive to Systemic Steroid Therapy: A Multicenter, Open-Label, Single-Arm Study.
     J Dermatol. 2025 Jul 14. doi: 10.1111/1346-8138.17860.
     PubMed     Abstract available
     
     
     
102. CHEN HC, Chen YC, Chuang MH, Chien WC, et al
     Increased Risk of Chronic Kidney Disease in Atopic Dermatitis: A Nationwide, Population-Based Cohort Analysis.
     J Dermatol. 2025 Jul 10. doi: 10.1111/1346-8138.17841.
     PubMed     Abstract available
     
     
     
103. MAIONE V, Venturuzzo A, Bighetti S, Romano C, et al
     NEVIGRAV Study: A Case-Control Analysis on Changes in Melanocytic Nevi During Pregnancy.
     J Dermatol. 2025 Jul 7. doi: 10.1111/1346-8138.17848.
     PubMed     Abstract available
     
     
     
104. WATABE D, Tsunoda K, Amano H
     Exacerbation of Psoriasis During Treatment With Ofatumumab for Multiple Sclerosis.
     J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17846.
     PubMed    
     
     
     
105. YOKOI K, Kiyohara E, Fujimoto M
     Multifocal Cutaneous Amyloidosis Mimicking Scleroderma Associated With Primary Cutaneous Marginal Zone Lymphoma.
     J Dermatol. 2025 Jul 2. doi: 10.1111/1346-8138.17850.
     PubMed    
     
     
     
106. LIM JH, Kang DH, Moon H, Kwon SH, et al
     The Role of T-Helper 17 Cells and Regulatory T Cells in Acute Diffuse and Total Alopecia: The Increased Function of Regulatory T Cells May Explain the Favorable Prognosis.
     J Dermatol. 2025;52:1138-1145.
     PubMed     Abstract available
     
     
     
107. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
     Predictors of Dermal Invasion and Sentinel Lymph Node Metastasis in Patients With Extramammary Paget's Disease Without Clinical Lymph Node Enlargement.
     J Dermatol. 2025;52:1152-1158.
     PubMed     Abstract available
     
     
     
108. DOU L, Chen F, He W, Wang J, et al
     Efficacy and Safety of Dupilumab Monotherapy in Patients With Dystrophic Epidermolysis Bullosa: A Retrospective Study of 8 Cases.
     J Dermatol. 2025;52:1159-1165.
     PubMed     Abstract available
     
     
     June 2025
109. FUKUDA A, Kishikawa S, Nakano E, Matsumoto Y, et al
     A Case of Microinvasive Malignant Hidroacanthoma Simplex/Porocarcinoma With Folliculo-Sebaceous Differentiation Only at Lymph Nodes Metastases With Absence of YAP1, PAK1/2/3 Fusions.
     J Dermatol. 2025 Jun 30. doi: 10.1111/1346-8138.17839.
     PubMed    
     
     
     
110. MISHLAB S, Horowitz N, Bergman R
     Refractory Facial Cutaneous B-Cell Pseudolymphoma in an Atopic Patient Responsive to Dupilumab.
     J Dermatol. 2025 Jun 28. doi: 10.1111/1346-8138.17842.
     PubMed    
     
     
     
111. MUKAIYAMA R, Yamamoto T
     Subcutaneous Sarcoidosis of the Lower Legs Mimicking Sclerosing Panniculitis in a Rheumatoid Arthritis Patient Under Golimumab Therapy.
     J Dermatol. 2025 Jun 27. doi: 10.1111/1346-8138.17836.
     PubMed    
     
     
     
112. ABE M, Igarashi A, Kitajima H, Toyama H, et al
     Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment for Atopic Dermatitis-Induced Rash on the Face and Neck: Efficacy at Reducing Local Side Effects of Topical Steroid and Tacrolimus Ointment.
     J Dermatol. 2025 Jun 26. doi: 10.1111/1346-8138.17817.
     PubMed     Abstract available
     
     
     
113. KITANO T, Horii M, Kudo K, Nishio J, et al
     Disrupted B-Cell Cytokine Homeostasis in Psoriasis: The Impact of Elevated IL-6 and Impaired IL-10 Production.
     J Dermatol. 2025 Jun 20. doi: 10.1111/1346-8138.17804.
     PubMed     Abstract available
     
     
     
114. HASE T, Fujita Y, Miyamoto K, Shimizu S, et al
     Refractory Post-Zoster Eosinophilic Dermatitis of the Eyelids Successfully Treated With Mycophenolate Mofetil.
     J Dermatol. 2025 Jun 20. doi: 10.1111/1346-8138.17833.
     PubMed     Abstract available
     
     
     
115. FUKUSHIMA S, Ito T, Asai J, Igaki H, et al
     Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025.
     J Dermatol. 2025 Jun 13. doi: 10.1111/1346-8138.17740.
     PubMed     Abstract available
     
     
     
116. KIM MC, Gu MJ, Park YS, Kim JG, et al
     Cutaneous Mature Plasmacytoid Dendritic Cell Proliferation in Primary Myelofibrosis: A Case Report.
     J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17803.
     PubMed    
     
     
     
117. YOSHIKAWA S, Kikuchi K, Nozawa K, Nakai Y, et al
     Facial Skin With Conspicuous Enlarged Pores Closely Related to Severity of Facial Acneiform Rash and Therapeutic Effects of EGFR Inhibitors in RAS Wild-Type Metastatic Colorectal Cancer: Ancillary Analysis of FAEISS Study (NCCH1512).
     J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17813.
     PubMed     Abstract available
     
     
     
118. KADONO T, Yamamoto M, Aoyama Y, Nakajima K, et al
     CARD14-Associated Papulosquamous Eruption (CAPE) With Ichthyosis and Malignant Melanoma.
     J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17807.
     PubMed    
     
     
     
119. KAWASE K, Mizutani Y, Inoue M, Akita H, et al
     A Case of Facial-Type Acquired Dermal Melanocytosis on the Lips Successfully Treated With Laser Therapy.
     J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17800.
     PubMed    
     
     
     
120. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
     Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
     J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
     PubMed    
     
     
     
121. SHIBA M, Hagino T, Saeki H, Fujimoto E, et al
     The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis.
     J Dermatol. 2025 Jun 2. doi: 10.1111/1346-8138.17812.
     PubMed    
     
     
     
122. MAEKAWA T, Ito T, Idezuki T, Ota M, et al
     Wound, Pressure Ulcer and Burn Guidelines (2023)-5: Guidelines for the Management of Lower Leg Ulcers/Varicose Veins, Third Edition Wound/Pressure Ulcer/Burn Guidelines Drafting Committee (Lower Leg Ulcers/Varicose Veins Group).
     J Dermatol. 2025;52:e481-e528.
     PubMed     Abstract available
     
     
     
123. ISEI T, Abe M, Ikegami R, Kato H, et al
     Wound, pressure ulcer, and burn guidelines - 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition.
     J Dermatol. 2025;52:e391-e429.
     PubMed     Abstract available
     
     
     
124. LEE BH, Chung KB, Jang H, Jung YW, et al
     HLA-B51 Positivity Correlates With Symptom Completeness From Recurrent Aphthous Stomatitis to Complete Behcet's Disease.
     J Dermatol. 2025;52:1001-1007.
     PubMed     Abstract available
     
     
     
125. TONE Y, Matsui M, Park A, Otani S, et al
     A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
     J Dermatol. 2025;52:1066-1069.
     PubMed     Abstract available
     
     
     
126. AVALLONE G, Maronese CA, Zussino M, Muratori S, et al
     Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
     J Dermatol. 2025;52:983-1000.
     PubMed     Abstract available
     
     
     
127. WANG L, Zhang J, Liu Y, Chen Z, et al
     A novel LSS variant leading to hypotrichosis with pseudoainhum.
     J Dermatol. 2025;52:1103-1106.
     PubMed     Abstract available
     
     
     
128. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
     Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
     J Dermatol. 2025;52:1015-1030.
     PubMed     Abstract available
     
     
     
129. OTSUKA A, Tsunemi Y, Nonaka Y
     Impact of shared decision-making in onychomycosis treatment: A cross-sectional study based on the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
     J Dermatol. 2025;52:1031-1038.
     PubMed     Abstract available
     
     
     
130. NORIMATSU Y, Hamada T, Ito K, Kimura E, et al
     The importance of pseudohyperchloremia for the diagnosis of bromoderma.
     J Dermatol. 2025;52:1078-1082.
     PubMed     Abstract available
     
     
     
131. LU L, Feng J, Zhang S, He H, et al
     Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review.
     J Dermatol. 2025;52:1008-1014.
     PubMed     Abstract available
     
     
     May 2025
132. SUGAI S, Takamura S, Fukuda T
     Effect of IL-23p19 Inhibitors for Psoriasis With Bullous Pemphigoid: Clinical Insights From Two Cases.
     J Dermatol. 2025 May 30. doi: 10.1111/1346-8138.17805.
     PubMed    
     
     
     
133. YAMAZAKI K, Tomita K, Masuda Y, Yagi H, et al
     Successful Treatment of Both Cutaneous and Extracutaneous Lesions in Systemic Sarcoidosis With Tranilast.
     J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17765.
     PubMed    
     
     
     
134. LIU Y, He H, Zhang C, Pan W, et al
     A Wool Hat-A Case of Scalp Psoriasis.
     J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17793.
     PubMed    
     
     
     
135. NAKANO E, Ogata D, Namikawa K, Yamazaki N, et al
     Real-World Efficacy and Safety of Anti-PD-1 Antibody Therapy for Patients With Advanced Cutaneous Squamous Cell Carcinoma: A Single-Center Retrospective Study in Japan.
     J Dermatol. 2025 May 23. doi: 10.1111/1346-8138.17799.
     PubMed     Abstract available
     
     
     
136. HIRANO S, Ikuno Y, Yamaguchi A, Takahashi T, et al
     Early-Stage Limited Cutaneous Systemic Sclerosis Successfully Treated With Guselkumab: Possibility of Early Intervention in the Pathogenesis.
     J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17796.
     PubMed    
     
     
     
137. CHARBEL N, Saade D, Maalouly M, Kreidieh F, et al
     Kaposi Sarcoma's Silent Symphony: An Atypical Auricular Presentation.
     J Dermatol. 2025 May 22. doi: 10.1111/1346-8138.17797.
     PubMed    
     
     
     
138. YATSUZUKA K, Muto J, Kohri N, Yoshida S, et al
     Complete Resolution of Residual Psoriasis by Adding Tapinarof Cream to Tildrakizumab: A Case Report.
     J Dermatol. 2025 May 20. doi: 10.1111/1346-8138.17792.
     PubMed    
     
     
     
139. JIA DD, Xu Y, Ren ZW, Li LQ, et al
     Is One Year Enough? Extended Adjuvant Dabrafenib Plus Trametinib for Chinese Patients With Resected Stage III Melanoma.
     J Dermatol. 2025 May 14. doi: 10.1111/1346-8138.17779.
     PubMed     Abstract available
     
     
     
140. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
     Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study.
     J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17764.
     PubMed     Abstract available
     
     
     
141. TSUBOI S, Yatsuzuka K, Kohri N, Yoshida S, et al
     Severe Exacerbation of Psoriasis Vulgaris With Topical Imiquimod Therapy: A Case Report.
     J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17782.
     PubMed    
     
     
     
142. NISHIMURA K, Kimura A, Nakamura A, Takatsuka S, et al
     Impact of Surgical Delay on Prognosis in Patients With Cutaneous Melanoma: A Single-Institution Retrospective Study in Japan.
     J Dermatol. 2025 May 10. doi: 10.1111/1346-8138.17773.
     PubMed     Abstract available
     
     
     
143. IWATA Y, Saito K, Matsushima J, Sugiura K, et al
     Generalized Pustular Psoriasis-Like Eruption Triggered by a G-CSF-Producing Lung Adenocarcinoma.
     J Dermatol. 2025 May 9. doi: 10.1111/1346-8138.17780.
     PubMed    
     
     
     
144. TAKAYAMA E, Ijuin K, Yoshioka A
     Postherpetic Isotopic Response Manifesting as Granulomatous Dermatitis With Maculopapular Rash, Induced by Immune Checkpoint Inhibitor Use.
     J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17776.
     PubMed    
     
     
     
145. MURAYAMA Y, Shojiguchi N, Kawasaki T, Inoue S, et al
     Metastatic Cutaneous Apocrine Adenocarcinoma Successfully Treated With Nivolumab.
     J Dermatol. 2025 May 8. doi: 10.1111/1346-8138.17777.
     PubMed    
     
     
     
146. JENG YC, Liao YC, Hong YK, Cheng HC, et al
     Immunoproteomic Response to IL-17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling.
     J Dermatol. 2025 May 6. doi: 10.1111/1346-8138.17772.
     PubMed    
     
     
     
147. JO SJ, Kim BS, Kim DH, Kim JH, et al
     Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study.
     J Dermatol. 2025;52:802-811.
     PubMed     Abstract available
     
     
     
148. NISHIDA E, Morita A
     The required absolute PASI score to achieve DLQI remission.
     J Dermatol. 2025;52:947-949.
     PubMed     Abstract available
     
     
     
149. LI C, Dai M, Gu Q, Lu K, et al
     Incidence of the Stevens-Johnson syndrome spectrum and its patterns in urban China.
     J Dermatol. 2025;52:897-906.
     PubMed     Abstract available
     
     
     
150. TANEMURA C, Nunotani M, Kawabata K, Morooka Y, et al
     Development of Japanese versions of the Autoimmune Bullous Disease Quality of Life and Treatment of Autoimmune Bullous Disease Quality of Life questionnaires.
     J Dermatol. 2025;52:812-830.
     PubMed     Abstract available
     
     
     
151. MATSUO M, Kato H, Kobayashi K, Nagai M, et al
     A case of pseudoangiomatous spindle-cell lipoma with unique MRI manifestations corresponding to distinct histological features.
     J Dermatol. 2025;52:943-946.
     PubMed     Abstract available
     
     
     
152. KAWAMOTO H, Fujii K, Aoki M, Goto K, et al
     Ultrasound findings of endocrine mucin-producing sweat gland carcinoma mimicking epidermal cysts: A case series and diagnostic challenges.
     J Dermatol. 2025;52:939-942.
     PubMed     Abstract available
     
     
     
153. HAMAGUCHI Y, Ueda-Hayakawa I, Kaneko U, Shimizu M, et al
     Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.
     J Dermatol. 2025;52:860-871.
     PubMed     Abstract available
     
     
     
154. MATSUO M, Zang X, Im D, Tanaka K, et al
     A case of multiple warty dyskeratomas overexpressing SERCA2 in acantholytic cells.
     J Dermatol. 2025;52:925-928.
     PubMed     Abstract available
     
     
     
155. XU Y, Yang Y, Zhan W, Zhao J, et al
     Associations of chronic kidney disease with hidradenitis suppurativa: A bidirectional Mendelian randomization study.
     J Dermatol. 2025;52:922-924.
     PubMed     Abstract available
     
     
     
156. TANEMURA A, Ma Y, Sakaki-Yumoto M, Hiro S, et al
     Clinical patterns of vitiligo in Japan: A descriptive study using the JMDC claims database.
     J Dermatol. 2025;52:831-840.
     PubMed     Abstract available
     
     
     April 2025
157. OKUBO Y, Morita A, Imafuku S, Tada Y, et al
     Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Japanese Patients With Plaque Psoriasis: In-Depth Analysis of Efficacy and Safety in the Phase 3 POETYK PSO-4 Trial.
     J Dermatol. 2025 Apr 30. doi: 10.1111/1346-8138.17744.
     PubMed     Abstract available
     
     
     
158. SHIN BS, Kim M, Suh MK, Lee YB, et al
     Effectiveness and Safety of Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis in Real-World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance Study.
     J Dermatol. 2025 Apr 28. doi: 10.1111/1346-8138.17757.
     PubMed     Abstract available
     
     
     
159. ASANO Y, Asai J, Ishii T, Iwata Y, et al
     Wound, pressure ulcer, and burn guidelines (2023)-4: Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers, third edition.
     J Dermatol. 2025 Apr 28. doi: 10.1111/1346-8138.17703.
     PubMed    
     
     
     
160. 
     Correction to "Clinical Background of Patients With Psoriasiform Skin Lesions due to Tumor Necrosis Factor Antagonist Administration at a Single Center".
     J Dermatol. 2025 Apr 27. doi: 10.1111/1346-8138.17751.
     PubMed    
     
     
     
161. HACINECIPOGLU F, Celik G, Kartal SP
     Efficacy and Safety of IL-17 and IL-23 Inhibitors in Elderly Patients With Plaque Psoriasis: A Real-World Study.
     J Dermatol. 2025 Apr 26. doi: 10.1111/1346-8138.17755.
     PubMed     Abstract available
     
     
     
162. TESHIMA R, Saito-Sasaki N, Hara N, Itamura M, et al
     Adult-Onset Langerhans Cell Histiocytosis Mimicking Erosive Pustular Dermatosis of the Scalp.
     J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17762.
     PubMed    
     
     
     
163. NAKAZATO S, Fujita Y, Anan T
     Microcystic Pseudoglandular Cutaneous Neurofibroma: The First Japanese Case of a Rare Neurofibroma Variant.
     J Dermatol. 2025 Apr 24. doi: 10.1111/1346-8138.17761.
     PubMed    
     
     
     
164. NAKAJIMA K, Miyagaki T, Okano T, Kadono T, et al
     Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study.
     J Dermatol. 2025 Apr 22. doi: 10.1111/1346-8138.17760.
     PubMed    
     
     
     
165. TOYOSHIMA R, Shibata S, Kakumoto T, Sato S, et al
     A Case of Parkinsonism Manifested by Exacerbation of Generalized Pustular Psoriasis.
     J Dermatol. 2025 Apr 21. doi: 10.1111/1346-8138.17750.
     PubMed    
     
     
     
166. LIAO V, Lavin L, Ong MM, Pulitzer MP, et al
     Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience.
     J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17747.
     PubMed     Abstract available
     
     
     
167. MORTATO E, Marcelli L, Tofani L, Belcastro A, et al
     Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study.
     J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17752.
     PubMed     Abstract available
     
     
     
168. SHEN MH, An HY, Shih CL
     Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
     J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
     PubMed     Abstract available
     
     
     
169. IGARI S, Ishikawa M, Ohtsuka M, Yamamoto T, et al
     Multiple Dermatofibromas and Solitary Basal Cell Carcinoma in a Patient With Sarcoidosis.
     J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17735.
     PubMed    
     
     
     
170. ADHANOM R, Kim C, Strong J, Martinez S, et al
     Cutaneous manifestations of WHIM syndrome.
     J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17733.
     PubMed     Abstract available
     
     
     
171. KASE Y, Hayashi R, Shimada K, Tsutsui Y, et al
     A Case of Pediatric Cutaneous Sarcoid Vasculitis.
     J Dermatol. 2025 Apr 9. doi: 10.1111/1346-8138.17736.
     PubMed    
     
     
     
172. FUJISHIGE A, Seko N
     Safety and effectiveness of secukinumab in Japanese patients with generalized pustular psoriasis: A post-marketing surveillance.
     J Dermatol. 2025 Apr 3. doi: 10.1111/1346-8138.17648.
     PubMed     Abstract available
     
     
     
173. YAMAMURA S, Myangat TM, Sawamura S, Shimada S, et al
     Serum circulating S100A7 and S100A15 DNA copies are elevated in patients with psoriasis and atopic dermatitis.
     J Dermatol. 2025 Apr 1. doi: 10.1111/1346-8138.17727.
     PubMed     Abstract available
     
     
     
174. ZHANG X, Ye Y, Sun W, Sheng Y, et al
     Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial.
     J Dermatol. 2025;52:603-614.
     PubMed     Abstract available
     
     
     
175. OKUBO Y, Murakami M, Kobayashi S, Tsuji S, et al
     Risankizumab in Japanese patients with moderate-to-severe palmoplantar pustulosis: Results from the randomized, phase 3 JumPPP study.
     J Dermatol. 2025;52:593-602.
     PubMed     Abstract available
     
     
     
176. LI YH, Chuang SH, Yang HJ
     Systematic review and meta-analysis of peripheral blood inflammatory markers in hidradenitis Suppurativa.
     J Dermatol. 2025;52:583-592.
     PubMed     Abstract available
     
     
     
177. KOGA H, Ishii N, Tsutsumi M, Teye K, et al
     Correlation of BP180, BP230, and type VII collagen antibody titers in serum, blister fluid, erosion, and saliva in pemphigoid diseases.
     J Dermatol. 2025;52:744-748.
     PubMed     Abstract available
     
     
     
178. CHEN Y, Li J, Tang Y, Chong S, et al
     Corticosteroids combined with low-dose methotrexate in the treatment of pemphigus vulgaris: A retrospective cohort study.
     J Dermatol. 2025;52:695-700.
     PubMed     Abstract available
     
     
     
179. TOCHIGI M, Takamiya Y, Ochiai S, Anzawa K, et al
     A case of warts in toe webs due to HPV type 7: Case report and literature review.
     J Dermatol. 2025;52:754-757.
     PubMed     Abstract available
     
     
     
180. MIYAZAKI K, Kunimoto K, Yasue S, Endo S, et al
     Biomarkers associated with progression of infantile hemangioma: Exploratory study.
     J Dermatol. 2025;52:712-725.
     PubMed     Abstract available
     
     
     
181. WADA-IRIMADA M, Takahashi T, Sekine M, Okazaki T, et al
     Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.
     J Dermatol. 2025;52:701-711.
     PubMed     Abstract available
     
     
     
182. CHEN X, Zhang B, Mao X, Wang Y, et al
     Clinical characteristics of bullous pemphigoid patients of different ages and the possible mechanism.
     J Dermatol. 2025;52:672-681.
     PubMed     Abstract available
     
     
     
183. SUGAYA M, Nagashima A, Nakamura R, Yano M, et al
     Treatment of facial reactive B-cell rich lymphoid proliferation with dapsone.
     J Dermatol. 2025;52:735-739.
     PubMed     Abstract available
     
     
     
184. MIURA G, Maeda T, Ujiie H
     Dermoscopic findings in two cases of trichogerminoma.
     J Dermatol. 2025;52:730-734.
     PubMed     Abstract available
     
     
     
185. MIZAWA M, Makino T, Furukawa F, Shimizu T, et al
     Clinical characterization of mycosis fungoides with abnormal light reactions induced by narrow-band UVB therapy: A review of a single-center experience.
     J Dermatol. 2025;52:726-729.
     PubMed     Abstract available
     
     
     March 2025
186. TADA Y, Sugiura Y, Kamishima M, Takahashi S, et al
     Real-world safety and effectiveness of guselkumab in patients with psoriasis: A post-marketing surveillance study through up to week 52 in Japan.
     J Dermatol. 2025 Mar 29. doi: 10.1111/1346-8138.17710.
     PubMed     Abstract available
     
     
     
187. LIU Z, Cheng N, Zheng S, Chen L, et al
     Persistent exanthema mainly on the trunk with pathologically dermal interstitial mucin as anti-HMGCR myopathy-associated skin rash: Case series.
     J Dermatol. 2025 Mar 28. doi: 10.1111/1346-8138.17717.
     PubMed     Abstract available
     
     
     
188. LIU T, Chang J
     Lichen nitidus on the penis.
     J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17719.
     PubMed    
     
     
     
189. CHO YT, Chou HI, Chan TC, Chen YC, et al
     Disease burden and treatment preference for moderate-to-severe atopic dermatitis in Taiwan: A discrete-choice experiment.
     J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17721.
     PubMed     Abstract available
     
     
     
190. KIMURA A, Ito T, Abe R, Ujiie H, et al
     Toxic epidermal necrolysis resulting in lip synechiae.
     J Dermatol. 2025 Mar 26. doi: 10.1111/1346-8138.17715.
     PubMed    
     
     
     
191. AMAGAI R, Fujimura T, Kambayashi Y, Takahashi-Watanabe M, et al
     Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.
     J Dermatol. 2025 Mar 25. doi: 10.1111/1346-8138.17718.
     PubMed     Abstract available
     
     
     
192. YAMAMOTO K, Okamura K, Saito T, Suzuki T, et al
     Hypopigmented malignant melanoma in a patient with oculocutaneous albinism type 4.
     J Dermatol. 2025 Mar 20. doi: 10.1111/1346-8138.17711.
     PubMed    
     
     
     
193. MAKI T, Murakami M, Takeichi T, Noda T, et al
     Cutaneous inflammation with upregulated interleukin-36gamma and TNFalpha in a patient with loricrin keratoderma.
     J Dermatol. 2025 Mar 19. doi: 10.1111/1346-8138.17708.
     PubMed    
     
     
     
194. ONDA M, Hagino T, Saeki H, Fujimoto E, et al
     Long-term maintenance of responses to bimekizumab treatment in moderate-to-severe psoriasis: A real-world comparison of Q4W versus Q8W dosing or bio-naive versus bio-switched patients.
     J Dermatol. 2025 Mar 14. doi: 10.1111/1346-8138.17700.
     PubMed     Abstract available
     
     
     
195. IGARI S, Yamamoto T
     A unique case of systemic lupus erythematosus presenting with interstitial granulomatous dermatitis at onset and palisaded neutrophilic granulomatous dermatitis at relapse.
     J Dermatol. 2025 Mar 14. doi: 10.1111/1346-8138.17709.
     PubMed    
     
     
     
196. TORII H, Morita A, Yamamoto C, Dong J, et al
     Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.
     J Dermatol. 2025 Mar 13. doi: 10.1111/1346-8138.17695.
     PubMed     Abstract available
     
     
     
197. MORITA A, Imafuku S, Tada Y, Okubo Y, et al
     Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO-1, PSO-4, and LTE trials.
     J Dermatol. 2025 Mar 11. doi: 10.1111/1346-8138.17685.
     PubMed     Abstract available
     
     
     
198. AL-CHAER RN, Folkmann M, Martensson NL, Feldt-Rasmussen U, et al
     Cutaneous manifestations of Fabry disease: A systematic review.
     J Dermatol. 2025 Mar 7. doi: 10.1111/1346-8138.17690.
     PubMed     Abstract available
     
     
     
199. KARABINOS A, Hrebenar P, Hyblova M, Tomkova E, et al
     A severe ABCC6-induced generalized arterial calcification of infancy overshadowed by the EGFR-associated neonatal inflammatory skin and bowel disease 2 in a Roma girl.
     J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17682.
     PubMed     Abstract available
     
     
     
200. JINNIN M, Shimokawa T, Kishi A, Hayashi N, et al
     Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial.
     J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17688.
     PubMed     Abstract available
     
     
     
201. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
     Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study.
     J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17672.
     PubMed     Abstract available
     
     
     
202. TAKEUCHI S, Zeze N, Imayama S, Nakahara T, et al
     Case of allergic contact dermatitis caused by polyurethane elastic cannula.
     J Dermatol. 2025 Mar 5. doi: 10.1111/1346-8138.17687.
     PubMed    
     
     
     
203. DORFER S, Ablinger M, Wimmer M, Hummel JI, et al
     Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.
     J Dermatol. 2025;52:423-431.
     PubMed     Abstract available
     
     
     
204. HAUBER B, Whichello C, Mauer J, Law E, et al
     Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.
     J Dermatol. 2025;52:510-514.
     PubMed     Abstract available
     
     
     
205. SILVER SM, Houghton K, Hitchens A, Ansquer VD, et al
     Real-world assessment of the patient profile, clinical characteristics, treatment patterns, and outcomes associated with erythropoietic and X-linked protoporphyria.
     J Dermatol. 2025;52:416-422.
     PubMed     Abstract available
     
     
     
206. KUBO A
     History and prospects of Nagashima-type palmoplantar keratosis, the most common palmoplantar keratoderma in east Asian populations.
     J Dermatol. 2025;52:408-415.
     PubMed     Abstract available
     
     
     
207. KIM MH
     Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID-19 infection: A nationwide population-based study.
     J Dermatol. 2025;52:499-504.
     PubMed     Abstract available
     
     
     
208. LUO H, Chen Y, Li J, Yang Y, et al
     Inflammatory proteins and hidradenitis suppurativa: Insights from genetic correlation and Mendelian randomization.
     J Dermatol. 2025;52:481-492.
     PubMed     Abstract available
     
     
     
209. DEMIRGIL F, Kugu N, Yilmaz Y
     Traumatic experiences, dissociative symptoms, and alexithymia in patients with alopecia areata.
     J Dermatol. 2025;52:452-459.
     PubMed     Abstract available
     
     
     
210. KIM BR, Lee KH, Paik K, Kim M, et al
     Comorbid diseases in bullous pemphigoid: A population-based case-control study.
     J Dermatol. 2025;52:460-471.
     PubMed     Abstract available
     
     
     
211. LI Z, Xie S, Xu X, Chen Z, et al
     Phenotypic and genotypic analysis of SERPINA12-related autosomal recessive palmoplantar keratoderma in southwestern China.
     J Dermatol. 2025;52:545-550.
     PubMed     Abstract available
     
     
     
212. WANG L, Huang J, Fang L, Zhou Y, et al
     Kodamaea ohmeri infection can be the causative agent of secondary infections of intertrigo: A case study.
     J Dermatol. 2025;52:541-544.
     PubMed     Abstract available
     
     
     
213. HAYASHI D, Kashiwada-Nakamura K, Noguchi H, Matsumoto T, et al
     Onychomycosis caused by Aspergillus species belonging to section Circumdati.
     J Dermatol. 2025;52:536-540.
     PubMed     Abstract available
     
     
     
214. CHEN Y, Xie S, Geng J, Li Z, et al
     Biallelic pathogenic variants in the LSS gene cause congenital alopecia-cataract syndrome.
     J Dermatol. 2025;52:531-535.
     PubMed     Abstract available
     
     
     
215. ULLAH K, Ahmed S, Cesarato N, Xiong X, et al
     Novel pathogenic variants in HR underlie atrichia with papular lesions in a cohort of 10 families.
     J Dermatol. 2025;52:515-519.
     PubMed     Abstract available
     
     
     
216. GONG Z, Yang S, Ling S, Wang H, et al
     Dermatopathological features and successful treatment with topical antioxidant for ichthyosiform lesions in Mitchell syndrome caused by an ACOX1 variant.
     J Dermatol. 2025;52:445-451.
     PubMed     Abstract available
     
     
     February 2025
217. SEGAWA Y, Takahashi T, Mikami Y, Takahashi T, et al
     A case of systemic sclerosis accompanying psoriasis successfully treated with brodalumab.
     J Dermatol. 2025 Feb 26. doi: 10.1111/1346-8138.17686.
     PubMed    
     
     
     
218. IMAFUKU S, Satoh A, Arima H, Tsuruta N, et al
     Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form-36, and other patient-reported outcomes.
     J Dermatol. 2025 Feb 25. doi: 10.1111/1346-8138.17629.
     PubMed     Abstract available
     
     
     
219. URATA K, Myangat TM, Kajihara I, Sawamura S, et al
     Increased circulating interleukin 36gamma DNA copies in psoriasis.
     J Dermatol. 2025 Feb 20. doi: 10.1111/1346-8138.17678.
     PubMed    
     
     
     
220. KAWAMOTO M, Sakai T, Uchimura K, Shono T, et al
     Anaphylaxis triggered by dog contact and exhaustion in a dog-allergic patient with atopic dermatitis.
     J Dermatol. 2025 Feb 17. doi: 10.1111/1346-8138.17676.
     PubMed    
     
     
     
221. KINOSHITA M, Ogawa Y, Shimada S, Abe R, et al
     Intravenous immunoglobulin inhibits neutrophil extracellular traps in Stevens-Johnson syndrome/toxic epidermal necrolysis.
     J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17675.
     PubMed    
     
     
     
222. VAN BUCHEM-POST NF, Ouwerkerk W, Stalman EW, van Dam KPJ, et al
     Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
     J Dermatol. 2025 Feb 14. doi: 10.1111/1346-8138.17664.
     PubMed     Abstract available
     
     
     
223. ABE N, Higashi Y, Tateishi C, Kanekura T, et al
     Efficacy of granulocyte and monocyte adsorptive apheresis on skin and joint manifestations of palmoplantar pustulosis with pustulotic arthro-osteitis: A multicentric, prospective, observational study.
     J Dermatol. 2025 Feb 12. doi: 10.1111/1346-8138.17667.
     PubMed     Abstract available
     
     
     
224. OMASA H, Kakuta R, Terai H, Kawaida M, et al
     A case of epidermal growth factor receptor-mutant lung cancer with transformation from adenocarcinoma into small cell carcinoma suggested by histological investigation of skin metastasis.
     J Dermatol. 2025 Feb 11. doi: 10.1111/1346-8138.17666.
     PubMed    
     
     
     
225. ELRADI M, Hoseiny HAM, Marei A, Boghdadi G, et al
     Intralesional candida antigen versus intralesional varicella zoster vaccine in treatment of molluscum contagiosum: A new promising alternative.
     J Dermatol. 2025 Feb 10. doi: 10.1111/1346-8138.17660.
     PubMed     Abstract available
     
     
     
226. HORISAKI K, Yoshikawa S, Mori S, Omata W, et al
     Prognostic value of the CONUT score with immune checkpoint inhibitors as first-line therapy for metastatic malignant melanoma.
     J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17613.
     PubMed     Abstract available
     
     
     
227. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
     Long-term real-world effectiveness of deucravacitinib in psoriasis: A 52-week prospective study stratified by prior apremilast or biologic therapy.
     J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17665.
     PubMed     Abstract available
     
     
     
228. MA Y, Chachin M, Hirose T, Nakamura K, et al
     Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database.
     J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17643.
     PubMed     Abstract available
     
     
     
229. FUJII Y, Takeichi T, Yamashita Y, Okumura T, et al
     Concurrent wild-type transthyretin amyloidosis and psoriasis vulgaris in an elderly man.
     J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17670.
     PubMed    
     
     
     
230. LV J, Li H, Zheng Y, Lv T, et al
     Treating tislelizumab-induced ulcerative lichenoid drug eruption with baricitinib in a patient with lung cancer.
     J Dermatol. 2025 Feb 7. doi: 10.1111/1346-8138.17662.
     PubMed    
     
     
     
231. BONCIANI D, Della Bella C, Corra A, Galano A, et al
     The impact of antibiotic therapy in psoriasis patients with active streptococcal infection: A prospective study.
     J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17645.
     PubMed     Abstract available
     
     
     
232. MIZUKAWA Y, Hama N, Niihara H, Miyagawa F, et al
     Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
     J Dermatol. 2025 Feb 3. doi: 10.1111/1346-8138.17609.
     PubMed     Abstract available
     
     
     
233. MORITA T, Hayama K, Ishii N, Koga H, et al
     Pemphigoid with autoantibodies exclusively reacting with gamma2-subunit of laminin-332 in a patient with psoriasis vulgaris.
     J Dermatol. 2025 Feb 1. doi: 10.1111/1346-8138.17650.
     PubMed    
     
     
     
234. KAVVALOU E, Krasagakis K, Chlouverakis G, Xekouki P, et al
     Association of statins, gliptins, and antipsychotics with bullous pemphigoid: A case-control study in the Cretan population.
     J Dermatol. 2025;52:291-298.
     PubMed     Abstract available
     
     
     
235. ITO T, Kukino R, Sarayama Y, Tanioka M, et al
     Wound, Pressure Ulcer, and Burn Guidelines-5: Guidelines for the management of lower leg ulcers and varicose veins, second edition.
     J Dermatol. 2025;52:e49-e69.
     PubMed     Abstract available
     
     
     
236. ZENG Q, Lu W, Ye Y, Li M, et al
     Variations in RASA1 and EPHB4 in Chinese patients with capillary malformation-arteriovenous malformation.
     J Dermatol. 2025;52:377-382.
     PubMed     Abstract available
     
     
     
237. YAMAMOTO T, Yamanaka K, Yamasaki K, Isaji H, et al
     Real-world safety and effectiveness of adalimumab in patients with pyoderma gangrenosum: Interim analysis of a post-marketing observational study in Japan.
     J Dermatol. 2025;52:270-280.
     PubMed     Abstract available
     
     
     
238. YAMAMOTO T
     Erythroderma in the elderly.
     J Dermatol. 2025;52:221-227.
     PubMed     Abstract available
     
     
     
239. LUO SY, Zhou KY, Wang QX, Feng L, et al
     Clinicopathological features of epithelioid hemangioma of 43 patients with long-term follow-up: A two-center retrospective study.
     J Dermatol. 2025;52:329-336.
     PubMed     Abstract available
     
     
     
240. ENCARNACION MRN, Kawai R, Kuwabiraki H, Ban N, et al
     Clinical characteristics and outcomes of autoimmune blistering diseases in Japan.
     J Dermatol. 2025;52:299-308.
     PubMed     Abstract available
     
     
     
241. KATAYAMA S, Izumi K, Ujiie I, Ujiie H, et al
     A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational study.
     J Dermatol. 2025;52:363-366.
     PubMed     Abstract available
     
     
     
242. NARASAKI M, Kato J, Sato S, Hida T, et al
     Extramammary Paget's disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failure.
     J Dermatol. 2025;52:359-362.
     PubMed     Abstract available
     
     
     
243. TAN H, Chen X, Chen Y, Ou X, et al
     Immune checkpoint inhibitor-associated bullous pemphigoid: A retrospective and real-world study based on the United States Food and Drug Administration adverse event reporting system.
     J Dermatol. 2025;52:309-316.
     PubMed     Abstract available
     
     
     
244. MORIOKE S, Moriwaki M, Tanaka A, Hide M, et al
     A case of chronic spontaneous urticaria with wheals lasting for more than a week.
     J Dermatol. 2025;52:344-347.
     PubMed     Abstract available
     
     
     
245. TOKURA Y, Yunoki M, Kondo S, Otsuka M, et al
     What is "eczema"?
     J Dermatol. 2025;52:192-203.
     PubMed     Abstract available
     
     
     
246. HIDE M, Kishimoto M, Kotera I, Oh A, et al
     Analysis of disease burden in patients with hereditary angioedema from Japan by patient-reported outcomes.
     J Dermatol. 2025;52:256-269.
     PubMed     Abstract available
     
     
     
247. MUROTA H, Matsumoto M, Arima K, Yoshida T, et al
     Current clinical practice of prurigo nodularis in Japan: A cross-sectional web-survey among dermatologists.
     J Dermatol. 2025;52:348-352.
     PubMed     Abstract available
     
     
     January 2025
248. MORITO K, Kado S, Okada H, Sato A, et al
     Cutaneous squamous carcinoma with pulmonary metastasis with cavity formation successfully treated with nivolumab.
     J Dermatol. 2025 Jan 29. doi: 10.1111/1346-8138.17649.
     PubMed    
     
     
     
249. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
     Real-world 52-week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index.
     J Dermatol. 2025 Jan 28. doi: 10.1111/1346-8138.17617.
     PubMed     Abstract available
     
     
     
250. SUGIYAMA A, Yano-Takamori A, Kojima K, Nishie H, et al
     Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events.
     J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17626.
     PubMed     Abstract available
     
     
     
251. NISHIHARA K, Fujii K, Aoki M, Hirano Y, et al
     Combination treatment of cultured epithelial autograft and meshed full-thickness skin graft for giant congenital melanocytic nevus.
     J Dermatol. 2025 Jan 16. doi: 10.1111/1346-8138.17529.
     PubMed    
     
     
     
252. TRUPIANO N, Young K, Echuri H, Maghfour J, et al
     Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
     J Dermatol. 2025 Jan 15. doi: 10.1111/1346-8138.17622.
     PubMed     Abstract available
     
     
     
253. YONEYAMA M, Hagino T, Saeki H, Fujimoto E, et al
     A predictive factor of oral candidiasis in psoriasis patients treated with bimekizumab: Longer disease duration.
     J Dermatol. 2025 Jan 11. doi: 10.1111/1346-8138.17623.
     PubMed    
     
     
     
254. HIGUCHI M, Hayashi R, Sato M, Oginezawa M, et al
     A case of toxic epidermal necrolysis like vancomycin-induced linear IgA bullous dermatosis without autoantibody for type VII collagen.
     J Dermatol. 2025 Jan 3. doi: 10.1111/1346-8138.17606.
     PubMed    
     
     
     
255. AN R, Sun DJ, Lei HX, He AR, et al
     Effect of Epstein-Barr virus on macrophage M2/M1 migration and EphA2 expression in adverse drug reactions.
     J Dermatol. 2025;52:87-96.
     PubMed     Abstract available
     
     
     
256. YAO QH, Zhi HL, Xia XJ, Liu ZH, et al
     The role of ingrown hairs in persistent kerion of children: A clinical study.
     J Dermatol. 2025;52:35-42.
     PubMed     Abstract available
     
     
     
257. SUZUKI S, Kamata M, Uchida H, Shimizu T, et al
     Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
     J Dermatol. 2025;52:122-131.
     PubMed     Abstract available
     
     
     
258. FUKUYAMA M, Kinoshita-Ise M, Ohyama M
     Long-term outcomes of intravenous corticosteroid pulse therapy for rapidly progressive alopecia areata: A single-center retrospective analysis of 106 cases and usefulness evaluation of a scoring system originally designed for half-year efficacy predic
     J Dermatol. 2025;52:112-121.
     PubMed     Abstract available
     
     
     
259. TSUNEMI Y, Otsuka A, Nonaka Y
     Clinical inertia in onychomycosis treatment: results from the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
     J Dermatol. 2025;52:97-111.
     PubMed     Abstract available
     
     
     
260. SHIMIZU A, Mieko K, Yamaguchi K, Niwa O, et al
     Detection of human papillomavirus in plantar warts and its impact on outcome.
     J Dermatol. 2025;52:175-178.
     PubMed     Abstract available
     
     
     
261. FUKAURA R, Ato M, Murase C, Miyamoto Y, et al
     Buruli ulcer: An epidemiological update from Japan.
     J Dermatol. 2025;52:3-10.
     PubMed     Abstract available
     
     
     
262. MOCHIZUKI T, Anzawa K, Bernales-Mendoza AM, Shimizu A, et al
     Case of tinea corporis caused by a terbinafine-sensitive Trichophyton indotineae strain in a Vietnamese worker in Japan.
     J Dermatol. 2025;52:163-166.
     PubMed     Abstract available
     
     
     
263. HIDA T, Idogawa M, Ishikawa A, Okura M, et al
     A case of familial progressive hyperpigmentation with or without hypopigmentation presenting with hypopigmented striae along the lines of Blaschko.
     J Dermatol. 2025;52:159-162.
     PubMed     Abstract available
     
     
     
264. TSUNEMI Y, Naka W
     Exploratory study on short-term administration of oral fosravuconazole for tinea pedis.
     J Dermatol. 2025;52:79-86.
     PubMed     Abstract available
     
     
     
265. WANG H, Wu B, Luo M, Han Y, et al
     Association of hidradenitis suppurativa (HS) with waist circumference: A bidirectional two-sample Mendelian randomization study of HS with metabolic syndrome.
     J Dermatol. 2025;52:155-158.
     PubMed     Abstract available
     
     
     
266. KOC HA, Onal BS
     Relationship between acne vulgaris and attention deficit hyperactivity disorder in adolescent: A cross-sectional study.
     J Dermatol. 2025;52:50-55.
     PubMed     Abstract available
     
     
     
267. MUTO Y, Kinjyo K, Asano Y
     Successful treatment of Darier's disease with apremilast and review of reported cases.
     J Dermatol. 2025;52:138-141.
     PubMed     Abstract available
     
     
     December 2024
268. SAITO-SASAKI N, Aoki M, Fujii K, Yamamura K, et al
     Age over 90 years is an unfavorable prognostic factor for resectable cutaneous squamous cell carcinoma.
     J Dermatol. 2024 Dec 27. doi: 10.1111/1346-8138.17551.
     PubMed     Abstract available
     
     
     
269. HYOBU R, Ito T, Sakai N, Okura M, et al
     Granular C3 dermatosis with pustular psoriasis-like skin rash.
     J Dermatol. 2024 Dec 27. doi: 10.1111/1346-8138.17604.
     PubMed    
     
     
     
270. NATSUGA K
     Advanced phasing techniques in congenital skin diseases.
     J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17597.
     PubMed     Abstract available
     
     
     
271. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
     Predictive factors for responders to deucravacitinib treatment in patients with psoriasis.
     J Dermatol. 2024 Dec 26. doi: 10.1111/1346-8138.17601.
     PubMed     Abstract available
     
     
     
272. NISHIO J, Hatta N, Ishii T, Yamamoto K, et al
     CYLD novel splicing mutation in a patient with CYLD cutaneous syndrome with basal cell carcinomas.
     J Dermatol. 2024 Dec 23. doi: 10.1111/1346-8138.17584.
     PubMed    
     
     
     
273. SAEKI H, Ohya Y, Arakawa H, Ichiyama S, et al
     English version of clinical practice guidelines for the management of atopic dermatitis 2024.
     J Dermatol. 2024 Dec 20. doi: 10.1111/1346-8138.17544.
     PubMed     Abstract available
     
     
     
274. KAMADA H, Arakawa N, Kato M, Tanji T, et al
     Nemolizumab-induced exacerbation of atopic dermatitis.
     J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17589.
     PubMed    
     
     
     
275. NIKI M, Kubo Y
     A case of Bell palsy during the course of oral TYK2 inhibitor deucravacitinib therapy in psoriasis.
     J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17596.
     PubMed    
     
     
     
276. NAKANO F, Kan T, Ushio Y, Ito H, et al
     A case of malignant melanoma in which adalimumab was effective for steroid-resistant uveitis caused by dabrafenib/trametinib combination therapy.
     J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17594.
     PubMed    
     
     
     
277. AKIYAMA M
     Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease.
     J Dermatol. 2024 Dec 19. doi: 10.1111/1346-8138.17585.
     PubMed     Abstract available
     
     
     
278. IGARASHI A, Tsuji G, Murata R, Fukasawa S, et al
     A phase 2, randomized, double-blind, vehicle-controlled trial of tapinarof cream in Japanese pediatric patients with atopic dermatitis.
     J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17587.
     PubMed     Abstract available
     
     
     
279. MORIWAKI Y, Shiraishi M, Shen Q, Du Z, et al
     Experimental method for creating skin with acquired appendage dysfunction.
     J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17579.
     PubMed     Abstract available
     
     
     
280. MAEDA C, Kido I, Ohara Y, Kase M, et al
     A case of nevoid basal cell carcinoma syndrome with segmentally unilaterally arranged hypertrichosis and circumscribed palmar hypokeratosis histologically presenting as basal cell carcinoma.
     J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17593.
     PubMed    
     
     
     
281. KATO J, Hida T, Idogawa M, Tokino T, et al
     The genomic landscape of cutaneous squamous cell carcinoma in Japan.
     J Dermatol. 2024 Dec 15. doi: 10.1111/1346-8138.17592.
     PubMed     Abstract available
     
     
     
282. KIM R, Goto A, Kuroda H, Arichi I, et al
     Linear IgA/IgG bullous dermatosis presenting with refractory oral and esophageal erosions: A case report.
     J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17580.
     PubMed    
     
     
     
283. YATSUZUKA K, Yoshida S, Miura N, Kohri N, et al
     Effectiveness of guselkumab for avelumab-induced psoriasis in urothelial carcinoma: A case report.
     J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17583.
     PubMed    
     
     
     
284. HASHIMOTO T, Okuno S
     Practical guide for the diagnosis and treatment of localized and generalized cutaneous pruritus (chronic itch with no underlying pruritic dermatosis).
     J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17565.
     PubMed     Abstract available
     
     
     
285. SONG H, Cheng Y, Wang X, Hong X, et al
     The evaluation of Congo red staining combined with fluorescence microscopy in the diagnosis of primary cutaneous amyloidosis.
     J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17562.
     PubMed     Abstract available
     
     
     
286. SATOH T
     A new era for understanding and managing common pruritic skin conditions: How to define, diagnose, and treat?
     J Dermatol. 2024 Dec 12. doi: 10.1111/1346-8138.17574.
     PubMed    
     
     
     
287. TADA Y, Armstrong AW, Imafuku S, Okubo Y, et al
     Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study.
     J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17570.
     PubMed     Abstract available
     
     
     
288. TANAKA M, Miyagaki T, Kubo M, Okano T, et al
     Two cases of lymphoma arising in immune deficiency/dysregulation presenting as primary cutaneous anaplastic large cell lymphoma during oral tacrolimus therapy.
     J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17575.
     PubMed    
     
     
     
289. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
     Bimekizumab for the treatment of genital, scalp, and nail psoriasis: A 52-week real-world study.
     J Dermatol. 2024 Dec 2. doi: 10.1111/1346-8138.17569.
     PubMed    
     
     
     
290. PATHAK GN, Agarwal P, Wolfe SM, Patel KH, et al
     Pemphigus relapse: Mechanisms, risk factors, and agents associated with disease recurrence.
     J Dermatol. 2024;51:1533-1546.
     PubMed     Abstract available
     
     
     
291. JALEEL T, Mitchell B, Burge R, Cohee A, et al
     Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.
     J Dermatol. 2024;51:1547-1558.
     PubMed     Abstract available
     
     
     
292. MATSUO M, Zang X, Miyauchi T, Mizutani Y, et al
     A case of revertant mosaic-like normal-looking spots in a patient with erythroderma with IL36RN and CARD14 heterozygous mutations.
     J Dermatol. 2024;51:1669-1673.
     PubMed     Abstract available
     
     
     
293. WIEDENMAYER N, Hogrefe K, Mihalceanu S, Winkler JK, et al
     Case report: A novel high-dose intravenous immunoglobulin preparation for the treatment of severe pemphigus vulgaris failing standard therapy.
     J Dermatol. 2024;51:1665-1668.
     PubMed     Abstract available
     
     
     
294. TANG KY, Zhang HL, Zhang XY, Jin HZ, et al
     Clinical and laboratory features between anti-TIF1gamma dermatomyositis with and without malignancy: 37 case series and a review.
     J Dermatol. 2024;51:1646-1657.
     PubMed     Abstract available
     
     
     
295. KIMURA A, Makino T, Kitayama S, Mizawa M, et al
     Immunohistopathological analyses of a case of pemphigus vegetans with antibodies against desmoglein 1 and desmocollins 1-3.
     J Dermatol. 2024;51:1711-1715.
     PubMed     Abstract available
     
     
     
296. KWON O, Wallace M, Messina P, Szende A, et al
     Treatment patterns and healthcare resource utilization among patients with alopecia areata: A real-world chart review in South Korea.
     J Dermatol. 2024;51:1622-1633.
     PubMed     Abstract available
     
     
     
297. LAN Q, Hua H, Zhou P
     Dystrophic epidermolysis bullosa characterized by mucosal lesions in a Chinese familial case with a novel compound heterozygous mutation of COL7A1.
     J Dermatol. 2024;51:1707-1710.
     PubMed     Abstract available
     
     
     
298. LAI PT, Tseng HC
     Adopting adalimumab combined surgery in the management of moderate to severe hidradenitis suppurativa: Experience from a single medical center in southern Taiwan.
     J Dermatol. 2024;51:1615-1621.
     PubMed     Abstract available
     
     
     
299. LI J, Xiao J, Xie X, Deng S, et al
     Individual joints involvement pattern in psoriatic arthritis: A cross-sectional study in China.
     J Dermatol. 2024;51:1607-1614.
     PubMed     Abstract available
     
     
     
300. CAI L, Yan Y, Li Y, Lin J, et al
     Two cases of eosinophilic pustular folliculitis successfully treated with abrocitinib.
     J Dermatol. 2024;51:1694-1697.
     PubMed     Abstract available
     
     
     
301. OCHIAI S, Anzawa K, Yamaguchi R, Takamiya Y, et al
     Surface material analysis for human papillomavirus detection in nail Bowen's disease caused by HPV type 58.
     J Dermatol. 2024;51:1690-1693.
     PubMed     Abstract available
     
     
     November 2024
302. FUJISHIGE A, Seko N
     Safety and effectiveness of secukinumab subcutaneous injection in Japanese patients with psoriasis vulgaris and psoriatic arthritis: A post-marketing surveillance.
     J Dermatol. 2024 Nov 29. doi: 10.1111/1346-8138.17499.
     PubMed     Abstract available
     
     
     
303. LUO W, Yang X, Ren Y, Tao X, et al
     Cutaneous zosteriform endometrial cancer metastasis.
     J Dermatol. 2024 Nov 27. doi: 10.1111/1346-8138.17536.
     PubMed    
     
     
     
304. 
     Correction to "Automatic evaluation of nail psoriasis severity index using deep learning algorithm".
     J Dermatol. 2024 Nov 26. doi: 10.1111/1346-8138.17556.
     PubMed    
     
     
     
305. LIU SW, Wu SE, Chen YH, Soong CY, et al
     Educational video assistance in shared decision-making for psoriasis: Effectiveness and outcomes.
     J Dermatol. 2024 Nov 25. doi: 10.1111/1346-8138.17550.
     PubMed     Abstract available
     
     
     
306. ALHASSAN E, Christianakis S, DeClerck B, Crew AB, et al
     Cutaneous lupus erythematosus following immunoglobulin therapy in dermatomyositis.
     J Dermatol. 2024 Nov 25. doi: 10.1111/1346-8138.17553.
     PubMed    
     
     
     
307. SAKAI H, Minami-Hori M, Kuwahara S
     Malignancies in patients with psoriasis during and after biological therapy: A single-center experience.
     J Dermatol. 2024 Nov 16. doi: 10.1111/1346-8138.17554.
     PubMed     Abstract available
     
     
     
308. ADACHI T, Matsui T, Okata-Karigane U, Takahashi C, et al
     Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.
     J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17521.
     PubMed     Abstract available
     
     
     
309. TSAI TF, Tada Y, Kung C, Zhong Y, et al
     Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis.
     J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17448.
     PubMed     Abstract available
     
     
     
310. SAKIYAMA T, Miyake T, Furuta K, Kabashima K, et al
     A case of toxic epidermal necrolysis with hand-foot syndrome-like rash following tirabrutinib treatment.
     J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17541.
     PubMed    
     
     
     
311. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
     Effectiveness of long-term bimekizumab treatment and predictive factors for responders in moderate-to-severe psoriasis: A 52-week real-world study.
     J Dermatol. 2024 Nov 5. doi: 10.1111/1346-8138.17532.
     PubMed     Abstract available
     
     
     
312. KATSUMI T, Hayashi R, Takei S, Ansai O, et al
     Reevaluating hybrid neurofibroma/schwannoma: Predominance of schwannoma features despite CD34 positivity and initial neurofibroma diagnosis.
     J Dermatol. 2024;51:1461-1469.
     PubMed     Abstract available
     
     
     
313. SATOH T, Murota H, Aoyama Y, Hashimoto T, et al
     Prurigo chronica multiformis: Expert consensus of the Japanese Dermatological Association.
     J Dermatol. 2024;51:e376-e383.
     PubMed     Abstract available
     
     
     
314. MORITA A, Okubo Y, Imafuku S, Terui T, et al
     Spesolimab, the first-in-class anti-IL-36R antibody: From bench to clinic.
     J Dermatol. 2024;51:1379-1391.
     PubMed     Abstract available
     
     
     
315. MESINKOVSKA N, King B, Zhang X, Guttman-Yassky E, et al
     Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
     J Dermatol. 2024;51:1414-1424.
     PubMed     Abstract available
     
     
     
316. OTA M, Nobeyama Y, Asahina A
     Clinical course of psoriatic arthritis treated with biologics delineated with ultrasonography.
     J Dermatol. 2024;51:1476-1480.
     PubMed     Abstract available
     
     
     
317. TSUNEMI Y, Otsuka A, Nonaka Y
     Patient-physician perception gaps in setting treatment goals and communication including shared decision making: Results from the survey illuminating dialogues and insights in onychomycosis management (IDIOM survey).
     J Dermatol. 2024;51:1441-1453.
     PubMed     Abstract available
     
     
     October 2024
318. MUKAIYAMA R, Yamamoto T
     Hematologic diseases in patients with cutaneous sarcoidosis.
     J Dermatol. 2024 Oct 28. doi: 10.1111/1346-8138.17525.
     PubMed    
     
     
     
319. MAEDA S, Imazaki K, Shimizu K, Oishi K, et al
     BRAF/MEK inhibitor-induced tumor lysis syndrome in a patient with malignant melanoma.
     J Dermatol. 2024 Oct 22. doi: 10.1111/1346-8138.17507.
     PubMed    
     
     
     
320. HUYNH TN, Yamazaki F, Konrad RJ, Nishikawa Y, et al
     Circulating CD31 and resistin levels reflect different stages of coronary atherosclerosis in patients with psoriasis.
     J Dermatol. 2024 Oct 22. doi: 10.1111/1346-8138.17450.
     PubMed     Abstract available
     
     
     
321. CETINARSLAN T, Aydogdu I, Ermertcan AT
     Oral administration of ruxolitinib in psoriasis vulgaris: A case report of plaque psoriasis accompanied by myelofibrosis secondary to polisitemia vera successfully treated with oral ruxolitinib.
     J Dermatol. 2024 Oct 20. doi: 10.1111/1346-8138.17510.
     PubMed     Abstract available
     
     
     
322. CHOON SE, Foley PA, Asawanonda P, Fujita H, et al
     Asia-Pacific consensus recommendations on the management of generalized pustular psoriasis.
     J Dermatol. 2024 Oct 10. doi: 10.1111/1346-8138.17471.
     PubMed     Abstract available
     
     
     
323. CHEN Y, Geng J, Xiao Y, Zhou X, et al
     A case of peeling skin syndrome type 1 with novel CDSN gene variation successfully treated with upadacitinib.
     J Dermatol. 2024 Oct 8. doi: 10.1111/1346-8138.17489.
     PubMed     Abstract available
     
     
     
324. WANG B, Yang J, Wang Y, Liang FM, et al
     Clinical and genetic insights into ABCA12 variants in three Chinese families with ichthyosis: Genotype-phenotype correlation.
     J Dermatol. 2024 Oct 3. doi: 10.1111/1346-8138.17484.
     PubMed     Abstract available
     
     
     
325. OKAMURA K, Saito T, Arai Y, Suto H, et al
     Effective management of coexisting bullous pemphigoid and psoriasis with bimekizumab.
     J Dermatol. 2024 Oct 3. doi: 10.1111/1346-8138.17490.
     PubMed    
     
     
     
326. UESUGI-UCHIDA S, Fujimoto M, Asano Y, Endo H, et al
     Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort.
     J Dermatol. 2024;51:1290-1297.
     PubMed     Abstract available
     
     
     
327. FUKAURA R, Koizumi H, Akashi N, Imai S, et al
     Buruli ulcer with satellite lesions: A case report from Japan.
     J Dermatol. 2024;51:e360-e362.
     PubMed    
     
     
     
328. HISADA S, Takeuchi S, Tozawa T, Yamada Y, et al
     Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis.
     J Dermatol. 2024;51:1329-1334.
     PubMed     Abstract available
     
     
     
329. WANG R, Li R, Wang M
     Unexpected B lymphocytes depletion in a patient with pemphigus vulgaris after a single dose of 50 mg rituximab.
     J Dermatol. 2024;51:e365-e366.
     PubMed    
     
     
     
330. FUKUYAMA K, Yaguchi T
     Longitudinal melanonychia caused by Cladophialophora boppii: Dermoscopic findings prompting the suspicion of fungal melanonychia.
     J Dermatol. 2024;51:e356-e357.
     PubMed    
     
     
     
331. ZHENG J
     Regarding the risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
     J Dermatol. 2024;51:e349.
     PubMed    
     
     
     
332. KUSANO M, Ohashi T, Hiraiwa T, Hashimoto T, et al
     Scarring alopecia and nail loss in a patient with epidermolysis bullosa acquisita.
     J Dermatol. 2024;51:e333-e334.
     PubMed    
     
     
     
333. BAI J, Wang S, Chen X, Fang H, et al
     Secukinumab treatment for inflammatory linear verrucous epidermal nevus.
     J Dermatol. 2024;51:e344-e345.
     PubMed    
     
     
     
334. IRIE K, Takada M, Yamamoto T
     Guselkumab-induced paradoxical exacerbation of extra-palmoplantar lesions in a patient with palmoplantar pustulosis.
     J Dermatol. 2024;51:e342-e343.
     PubMed    
     
     
     
335. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
     Author reply to the letter regarding 'Dietary habits in adult Japanese patients with vitiligo'.
     J Dermatol. 2024;51:e370-e371.
     PubMed    
     
     
     
336. ISHIDA H, Noriki S
     A study of 25 cases tested with the dermatophyte test strip after oral foslavuconazole treatment for tinea unguium.
     J Dermatol. 2024;51:e331-e332.
     PubMed    
     
     
     
337. BAO HY, Wu XG
     Regarding the dietary habits in adult Japanese patients with vitiligo.
     J Dermatol. 2024;51:e369.
     PubMed    
     
     
     
338. SUMIOKI A, Saito K, Nishida H, Nishizono A, et al
     Intractable Nocardial mycetoma with possible colonisation by Candida species.
     J Dermatol. 2024;51:1364-1367.
     PubMed     Abstract available
     
     
     
339. CHO R, Nakajima S, Kaku Y, Tezuka J, et al
     Proteasome inhibitor-associated histiocytoid Sweet's syndrome: Clinical and histological similarities to Nakajo-Nishimura syndrome suggest a potential mechanism.
     J Dermatol. 2024;51:1355-1359.
     PubMed     Abstract available
     
     
     
340. OBARA K, Amoh Y
     A case of AA amyloidosis complicated by proliferating pilomatricoma and a review of the literature.
     J Dermatol. 2024;51:1360-1363.
     PubMed     Abstract available
     
     
     
341. LUO X, Ruan Z, Liu L
     Causal relationship between metabolic syndrome and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
     J Dermatol. 2024;51:1335-1349.
     PubMed     Abstract available
     
     
     
342. MINAKAWA S, Matsuzaki Y, Higashino T, Yamada N, et al
     A case of Hailey-Hailey disease with novel ATP2C1 gene variant (c.G925C) showing unusual phenotype.
     J Dermatol. 2024;51:e346-e348.
     PubMed    
     
     
     
343. JIN S, Yue C, Wang S, Wang P, et al
     Oral abrocitinib in the treatment of refractory dissecting cellulitis of the scalp: A case report.
     J Dermatol. 2024;51:e329-e330.
     PubMed    
     
     
     September 2024
344. YAMAMOTO J, Kambayashi Y, Kuroki S, Asano Y, et al
     Segmental lichen aureus: A case report of zosteriform distribution and severe pain with literature review.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17486.
     PubMed    
     
     
     
345. SUZUKI S, Hama N, Suzuki R, Yuki A, et al
     Two cases of lichen planus pigmentosus inversus improved by topical tacrolimus application and the avoidance of tight clothing.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17485.
     PubMed    
     
     
     
346. YAMAMOTO R, Kokubu H, Ikuno Y, Kato M, et al
     Anti-transcription intermediate factor 1-gamma antibody-positive dermatomyositis with refractory skin ulcers and rapid cancer progression.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17482.
     PubMed    
     
     
     
347. ZHENG B, Zhang Z, Zhou X, Li M, et al
     A mutation in the SREBF1 gene resulting in autosomal-dominant ichthyosis Follicularis, Atrichia, and photophobia syndrome.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17474.
     PubMed    
     
     
     
348. TSUKAMOTO T, Iwata Y, Ohmiya N, Sugiura K, et al
     A case of familial Mediterranean fever complicated by IgA vasculitis and psoriasis vulgaris.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17470.
     PubMed    
     
     
     
349. MORIMOTO K, Iwamoto Y, Kanazawa A, Okiyama N, et al
     Simultaneous skin infection of Mycobacterium chelonae and Nocardia thailandica.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17478.
     PubMed    
     
     
     
350. KAN Y, Horimoto K, Uhara H
     Successful treatment of nail psoriasis by switching to a TYK2 inhibitor after cyclosporine.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17469.
     PubMed    
     
     
     
351. ITAMOTO S, Miyazawa H, Natsuga K, Yamaga M, et al
     Association between nail psoriasis and obesity: A cross-sectional study at a single institution.
     J Dermatol. 2024 Sep 30. doi: 10.1111/1346-8138.17481.
     PubMed    
     
     
     
352. YOUN SW, Jo SJ, Park CJ, Kim DH, et al
     Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study.
     J Dermatol. 2024 Sep 27. doi: 10.1111/1346-8138.17446.
     PubMed     Abstract available
     
     
     
353. KITAYAMA S, Takemoto K, Matsui Y, Makino T, et al
     Remission of intercellular IgG/IgA dermatosis after treatment for cervical cancer.
     J Dermatol. 2024 Sep 24. doi: 10.1111/1346-8138.17473.
     PubMed    
     
     
     
354. OGAWA Y, Maejima E, Takeichi T, Okamoto T, et al
     Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab.
     J Dermatol. 2024 Sep 20. doi: 10.1111/1346-8138.17464.
     PubMed     Abstract available
     
     
     
355. FUKUDA A, Ogata D, Oshima Y, Nakano E, et al
     Grade 3 acute kidney injury caused anti-glomerular basement membrane nephritis during immune checkpoint inhibitor treatment for melanoma.
     J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17460.
     PubMed    
     
     
     
356. KOYAMA A, Li L, Yamamoto T, Taira H, et al
     Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study.
     J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17465.
     PubMed     Abstract available
     
     
     
357. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
     Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials.
     J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
     PubMed     Abstract available
     
     
     
358. HORISAKI K, Yoshikawa S, Omata W, Tsutsumida A, et al
     Comparison of efficacy between anti-PD-1 antibody monotherapy and nivolumab plus ipilimumab therapy as first-line immunotherapy for advanced mucosal melanoma in Japanese patients: A single-center, retrospective cohort study.
     J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17445.
     PubMed     Abstract available
     
     
     
359. LUO Z, Lyu Y, Dong W, Mei Z, et al
     Coexistence of Basan syndrome and cutaneous basal cell carcinoma: Genetic and clinical perspectives.
     J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17443.
     PubMed    
     
     
     
360. SATO T, Nakazono M, Ohyachi K, Okaniwa A, et al
     HPV 51-associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine.
     J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17454.
     PubMed    
     
     
     
361. OKUSE M, Soekawa M, Itakura A, Kawamura T, et al
     Perspectives of Japanese patients on psoriatic disease burden: Results from "Psoriasis and Beyond," the Global Psoriatic Disease Survey.
     J Dermatol. 2024 Sep 10. doi: 10.1111/1346-8138.17424.
     PubMed     Abstract available
     
     
     
362. KATO H, Kano S, Yoshimitsu M, Nakagawa Y, et al
     Comparative analysis of one-step and two-step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma.
     J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17398.
     PubMed     Abstract available
     
     
     
363. KAWANO N, Nakashima C, Otsuka A
     A case of eczematous paradoxical reactions on the extremities during tildrakizumab treatment for plaque psoriasis.
     J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17441.
     PubMed    
     
     
     
364. MORITA A, Okubo Y, Imafuku S, Tada Y, et al
     Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study.
     J Dermatol. 2024 Sep 4. doi: 10.1111/1346-8138.17444.
     PubMed     Abstract available
     
     
     
365. NOBEYAMA Y
     Rosacea in East Asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis.
     J Dermatol. 2024;51:1143-1156.
     PubMed     Abstract available
     
     
     
366. MIYACHI H, Sato D, Sakamaki K, Togawa Y, et al
     Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study.
     J Dermatol. 2024;51:1172-1179.
     PubMed     Abstract available
     
     
     
367. KITANO T, Koiwai T, Fujikawa K, Mori S, et al
     Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes.
     J Dermatol. 2024;51:1187-1198.
     PubMed     Abstract available
     
     
     
368. TORCHIA D
     Mosaic KRAS mutations cause an atypical variant of phacomatosis spilosebacea.
     J Dermatol. 2024;51:1262-1263.
     PubMed    
     
     
     
369. KATO J, Hida T, Idogawa M, Tokino T, et al
     Genomic profiles of Merkel cell carcinoma in Japan.
     J Dermatol. 2024;51:1259-1261.
     PubMed    
     
     
     
370. HAMMADI AA, Parmar NV, Farghaly M, Dallal SA, et al
     A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database.
     J Dermatol. 2024;51:1157-1171.
     PubMed     Abstract available
     
     
     
371. HIGUCHI S, Noguchi H, Matsumoto T, Nojo H, et al
     Terbinafine-resistant tinea pedis and tinea unguium in Japanese military personnel.
     J Dermatol. 2024;51:1256-1258.
     PubMed    
     
     
     
372. FU S, Lu H, Song XZ
     Multiple lupus vulgaris.
     J Dermatol. 2024;51:e289-e290.
     PubMed    
     
     
     
373. KUZUMI A, Yoshizaki A, Matsuda K, Nagai K, et al
     Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome.
     J Dermatol. 2024;51:1240-1244.
     PubMed     Abstract available
     
     
     
374. MUTO Y, Fujimura T, Takahashi A, Namikawa K, et al
     Analysis of surgical margins and prognostic factors in dermatofibrosarcoma protuberans after wide local excision: A multicenter study of 116 Japanese patients.
     J Dermatol. 2024;51:1225-1232.
     PubMed     Abstract available
     
     
     
375. WATANABE T, Watanabe Y, Asai C, Asami M, et al
     Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
     J Dermatol. 2024;51:1208-1215.
     PubMed     Abstract available
     
     
     
376. YASUNAGA S, Oya K, Ishii Y, Anju K, et al
     Milia-like appearance of vulvar syringoma.
     J Dermatol. 2024;51:e308-e309.
     PubMed    
     
     
     
377. OYA K, Ishii Y, Takeyama S, Homma Y, et al
     COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.
     J Dermatol. 2024;51:e304-e305.
     PubMed    
     
     
     
378. KAMIGA M, Hayashi S, Ikegami T, Tokoro S, et al
     Hereditary angioedema with a normal C1 inhibitor in Japanese man.
     J Dermatol. 2024;51:e298-e299.
     PubMed    
     
     
     
379. SAKIYAMA T, Nakamizo S, Kabashima K
     Comparative analysis of CAII and GCDFP-15 expression in sweat glands unveiling the pathophysiology of acquired idiopathic generalized anhidrosis.
     J Dermatol. 2024;51:e310-e311.
     PubMed    
     
     
     
380. SONG D, Yi Q, Zhuang K, Yang L, et al
     Unilateral heliotrope rash: A call for recognizing its warning significance in anti-MDA5 antibody-associated dermatomyositis.
     J Dermatol. 2024;51:e319-e320.
     PubMed    
     
     
     
381. MOLTRASIO C, Tricarico PM, Ronald MR, Lucas B, et al
     Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
     J Dermatol. 2024;51:e324-e325.
     PubMed    
     
     
     
382. KUROKAMI Y, Yamashita C, Yokoi K, Tonomura K, et al
     A rare case of metastatic extramammary Paget disease developing transfusion-related acute lung injury during chemotherapy.
     J Dermatol. 2024;51:e312-e313.
     PubMed    
     
     
     
383. TAKAYAMA E, Yoshioka A
     Herpes simplex virus infection with a marginal Nikolsky sign in an immunocompromised patient.
     J Dermatol. 2024;51:e314-e315.
     PubMed    
     
     
     
384. MASUYUKI R, Sato E, Imafuku S
     A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody.
     J Dermatol. 2024;51:1252-1255.
     PubMed     Abstract available
     
     
     August 2024
385. BERGMANN MS, Loft N, Schwarz CW, Kaur-Knudsen D, et al
     HLA-C*06:02 in Danish patients with psoriasis and response to biological treatment.
     J Dermatol. 2024 Aug 27. doi: 10.1111/1346-8138.17415.
     PubMed     Abstract available
     
     
     
386. KONDO M, Goto D, Habe K, Yamazoe N, et al
     Changes in skin bacterial flora during the healing process of ulcer caused by self-destruction of lymph nodes due to tuberculous lymphadenitis.
     J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17433.
     PubMed     Abstract available
     
     
     
387. HAMADA M, Hida T, Idogawa M, Tange S, et al
     Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome.
     J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17434.
     PubMed     Abstract available
     
     
     
388. HSIEH DM, Shang P, Gao Y, Zhao J, et al
     Successful treatment with spesolimab for generalized pustular psoriasis in an elderly patient with TRPM4 mutation.
     J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17431.
     PubMed    
     
     
     
389. SAITO H, Omatsu J, Takasaki Y, Osuji Y, et al
     Perianal cutaneous malakoplakia in a patient with anti-MDA5 dermatomyositis.
     J Dermatol. 2024 Aug 19. doi: 10.1111/1346-8138.17430.
     PubMed    
     
     
     
390. IGARASHI A, Tsuji G, Fukasawa S, Murata R, et al
     Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials.
     J Dermatol. 2024 Aug 16. doi: 10.1111/1346-8138.17423.
     PubMed     Abstract available
     
     
     
391. HIGASHINO T, Konomi M, Kubo A, Horinosono H, et al
     Coincidence of acral peeling skin syndrome and Nagashima-type palmoplantar keratosis in a Japanese pedigree with acral skin peeling.
     J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17422.
     PubMed     Abstract available
     
     
     
392. HAGINO T, Onda M, Saeki H, Fujimoto E, et al
     Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24-week real-world study.
     J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17427.
     PubMed     Abstract available
     
     
     
393. MATSUO M, Niwa H, Iwata H
     A case of metastasis of giant basal cell carcinoma in oculocutaneous albinism.
     J Dermatol. 2024 Aug 12. doi: 10.1111/1346-8138.17425.
     PubMed    
     
     
     
394. TAKAHASHI H, Morimoto H, Sugimura Y, Honda T, et al
     Primary localized cutaneous nodular amyloidosis of the scalp arising from folliculitis decalvans.
     J Dermatol. 2024 Aug 10. doi: 10.1111/1346-8138.17418.
     PubMed    
     
     
     
395. MINAKAWA F, Yamamoto T, Aoyama Y
     Simultaneous distinct cutaneous fungal infections with chromoblastomycosis due to Exophiala xenobiotica and hyalohyphomycosis due to Scedosporium apiospermum in a patient with severe cellular immunodeficiency.
     J Dermatol. 2024 Aug 5. doi: 10.1111/1346-8138.17412.
     PubMed     Abstract available
     
     
     
396. NODA T, Takeichi T, Tanahashi K, Muro Y, et al
     A case of pachyonychia congenita with a hotspot variant at Arg127 in KRT16: Disease severity assessment using AlphaMissense technology.
     J Dermatol. 2024;51:1134-1136.
     PubMed    
     
     
     
397. KLUIJVER LG, Wensink D, Wagenmakers MAEM, Huidekoper HH, et al
     Quality of life in children with erythropoietic protoporphyria: a case-control study.
     J Dermatol. 2024;51:1068-1078.
     PubMed     Abstract available
     
     
     
398. MATSUDA Y, Miyake T, Toda H, Tachibana K, et al
     The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis.
     J Dermatol. 2024;51:1108-1112.
     PubMed     Abstract available
     
     
     
399. SHIN SH, Kim JY, Kim SC, Kim JH, et al
     Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus.
     J Dermatol. 2024;51:1104-1107.
     PubMed     Abstract available
     
     
     
400. OKUBO A, Hanada M, Kodama S, Taniguchi N, et al
     Long-term follow-up study of the efficacy of fosravuconazole in the treatment of onychomycosis in elderly patients.
     J Dermatol. 2024;51:1091-1097.
     PubMed     Abstract available
     
     
     
401. INOUE T, Watabe D, Furukawa M, Goto M, et al
     Prevalence and risk factors for onychomycosis in acute care dermatology wards.
     J Dermatol. 2024;51:1079-1082.
     PubMed     Abstract available
     
     
     
402. NARUSE S, Takashima S, Fujita Y, Kataoka H, et al
     Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody.
     J Dermatol. 2024;51:e268-e269.
     PubMed    
     
     
     
403. LEE KH, Jeong JH, Park CJ, Kim YS, et al
     Resolution of extensive plantar verruca vulgaris but not facial verruca plana following nonavalent human papillomavirus vaccine: A case report and literature review.
     J Dermatol. 2024;51:e279-e281.
     PubMed    
     
     
     
404. FUKAURA R, Takeichi T, Noda T, Seishima M, et al
     A novel splicing CYLD variant associated with trichoepithelioma papulosum multiplex demonstrating intrafamilial severity variability.
     J Dermatol. 2024;51:e274-e276.
     PubMed    
     
     
     
405. YANO D, Ohsawa I, Suga Y, Mitsuishi T, et al
     Unusual clinical presentation of extragenital condyloma acuminatum.
     J Dermatol. 2024;51:e277-e278.
     PubMed    
     
     
     
406. IKUMI N, Fujita H
     Long-term control of spondylitis by short-term ixekizumab treatment in a patient with palmoplantar pustulosis.
     J Dermatol. 2024;51:e255-e256.
     PubMed    
     
     
     
407. NORIMATSU Y, Saku A, Kawashima H, Minagawa T, et al
     Polyarteritis nodosa with splenic rupture and multiple cerebral infarctions.
     J Dermatol. 2024;51:e259-e260.
     PubMed    
     
     
     
408. MATSUZAKI E, Kajihara I, Tomiguchi M, Kimura T, et al
     Effectiveness of trabectedin for radiation-induced angiosarcoma of the breast refractory to several anticancer drugs.
     J Dermatol. 2024;51:e257-e258.
     PubMed    
     
     
     
409. MISAKI M, Takeichi T, Omi M, Ito Y, et al
     Localized epidermolysis bullosa simplex caused by a previously unreported substitution in the linker 12 domain of keratin 14.
     J Dermatol. 2024;51:e264-e265.
     PubMed    
     
     
     
410. YANG XS, Wang TT, Ding YX, Chen YH, et al
     Concentrated growth factor therapy as cosmetic treatment in discoid lupus erythematosus.
     J Dermatol. 2024;51:1125-1128.
     PubMed     Abstract available
     
     
     
411. HUA H, Li M, Zhai X, Zhou S, et al
     Sleep quality correlates with effectiveness of ultrapulse fractional CO(2) laser in the treatment of facial atrophic acne scars.
     J Dermatol. 2024;51:1120-1124.
     PubMed     Abstract available
     
     
     
412. ZHAO A, Wang Y, Jia N, Lu F, et al
     Mosaic GJB2 mutations in widespread porokeratotic adnexal ostial nevus: Report of two patients.
     J Dermatol. 2024;51:1129-1133.
     PubMed     Abstract available
     
     
     
413. GUO Z, Guo M, Gui G, Liu Y, et al
     Emergence of verrucous psoriasis post-secukinumab therapy.
     J Dermatol. 2024 Aug 1. doi: 10.1111/1346-8138.17402.
     PubMed    
     
     
     July 2024
414. IM D, Ueda K, Niwa H, Tanaka K, et al
     A case of bullous pemphigoid associated with psoriasis showing no tissue-bound immunoglobulin G on the inflamed skin.
     J Dermatol. 2024 Jul 29. doi: 10.1111/1346-8138.17408.
     PubMed    
     
     
     
415. VAN DER VELDEN JJAJ, van Gisbergen MW, Kamps MAF, Janssen R, et al
     Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis.
     J Dermatol. 2024 Jul 29. doi: 10.1111/1346-8138.17395.
     PubMed     Abstract available
     
     
     
416. BUENO-MOLINA RC, Hernandez-Rodriguez JC, Zulueta-Dorado T, Pereyra-Rodriguez JJ, et al
     Pyrin-associated autoinflammation with neutrophilic dermatosis: A case report.
     J Dermatol. 2024 Jul 28. doi: 10.1111/1346-8138.17390.
     PubMed     Abstract available
     
     
     
417. ZUO Y, Zhang Y, Qu Z, Wang B, et al
     Defactinib inhibits FAK phosphorylation and regulates psoriasis via attenuating hyperproliferation of keratinocytes.
     J Dermatol. 2024 Jul 25. doi: 10.1111/1346-8138.17366.
     PubMed     Abstract available
     
     
     
418. OKAZAKI T, Takahashi T, Asano Y
     Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute-on-chronic pancreatitis: A case report.
     J Dermatol. 2024 Jul 25. doi: 10.1111/1346-8138.17406.
     PubMed    
     
     
     
419. CHEN J, Luo Y, Duan Y, Wang L, et al
     A double-blind pilot study of oral baricitinib in adult patients with lupus erythematosus panniculitis.
     J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17354.
     PubMed     Abstract available
     
     
     
420. OHATA C, Anezaki H, Yanase T, Katayama E, et al
     Real-world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study.
     J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17385.
     PubMed     Abstract available
     
     
     
421. WINKLER M, Albrecht JD, Sauer C, Kordass T, et al
     Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature.
     J Dermatol. 2024 Jul 19. doi: 10.1111/1346-8138.17339.
     PubMed     Abstract available
     
     
     
422. MIURA G, Watanabe M, Kosumi H, Nohara T, et al
     Blaschkoid granulomatous pigmented purpuric dermatosis in childhood.
     J Dermatol. 2024 Jul 17. doi: 10.1111/1346-8138.17379.
     PubMed    
     
     
     
423. SEKI T, Makino T, Hayashi M, Kitayama S, et al
     Repigmentation from the epidermis around the acrosyringium in vitiligo universalis.
     J Dermatol. 2024 Jul 15. doi: 10.1111/1346-8138.17388.
     PubMed    
     
     
     
424. WAKI Y, Nobeyama Y, Nakagawa H, Asahina A, et al
     Author reply to does dermatophytosis of the feet cause acral melanoma?
     J Dermatol. 2024 Jul 12. doi: 10.1111/1346-8138.17377.
     PubMed    
     
     
     
425. 
     Correction to "Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies".
     J Dermatol. 2024 Jul 8. doi: 10.1111/1346-8138.17362.
     PubMed    
     
     
     
426. AL-BUSANI H, Namiki T, Yokoyama K, Miura K, et al
     A combination of PET-CT and thallium-201 scintigraphy has a diagnostic potential in detecting systemic sarcoidosis in a patient with malignant melanoma.
     J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17372.
     PubMed    
     
     
     
427. INOZUME T, Fukushima S, Fukuda T, Harada K, et al
     Does dermatophytosis of the feet cause acral melanoma?
     J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17378.
     PubMed    
     
     
     
428. KWAN YH, Oh CC
     Brown pigmentation on skin post intravenous ferric carboxymaltose.
     J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17376.
     PubMed    
     
     
     
429. JINSHAN Z, Yong Q, Fangqi C, Juanmei C, et al
     The role of TNF-alpha as a potential marker for acute cutaneous lupus erythematosus in patients with systemic lupus erythematosus.
     J Dermatol. 2024 Jul 4. doi: 10.1111/1346-8138.17355.
     PubMed     Abstract available
     
     
     
430. ARRIETA VINAIXA A, Alonso Usero V, Moro R
     Extensive cornified Darier's disease: A rare presentation.
     J Dermatol. 2024;51:e225-e226.
     PubMed    
     
     
     
431. OHTSUKI M, Okubo Y, Saeki H, Igarashi A, et al
     Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study.
     J Dermatol. 2024;51:950-963.
     PubMed     Abstract available
     
     
     
432. RAN X, Ran Y
     The horizontal and vertical pathological perspectives of black dot ringworm hair.
     J Dermatol. 2024;51:e223-e224.
     PubMed    
     
     
     
433. RIINA L, Jari J, Laura H, Suvi-Paivikki S, et al
     Erythema nodosum in northern Finland between 1996 and 2019: A register-based study.
     J Dermatol. 2024;51:1017-1021.
     PubMed     Abstract available
     
     
     
434. YOKOI S, Iwata Y, Sugiura K
     A retrospective clinicopathological study of erythema nodosum.
     J Dermatol. 2024;51:985-990.
     PubMed     Abstract available
     
     
     
435. KIKUCHI N, Yamamoto T
     Serum cytokine profiles in a case of post-cesarean pyoderma gangrenosum.
     J Dermatol. 2024;51:e245-e246.
     PubMed    
     
     
     
436. NIIMURA Y, Kamata M, Ishikawa T, Nagata M, et al
     308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
     J Dermatol. 2024;51:977-984.
     PubMed     Abstract available
     
     
     
437. NAKA W, Tsunemi Y
     Effects of additional oral fosravuconazole l-lysine ethanolate therapy following inadequate response to initial treatment for onychomycosis: A multicenter, randomized controlled trial.
     J Dermatol. 2024;51:964-972.
     PubMed     Abstract available
     
     
     
438. BAX C, Aghdasi C, Fiorentino D
     Novel therapeutic targets in dermatomyositis.
     J Dermatol. 2024;51:920-926.
     PubMed     Abstract available
     
     
     
439. OKAZAKI T, Takahashi T, Asano Y
     Eosinophilic annular erythema successfully treated with dupilumab: A case report.
     J Dermatol. 2024;51:e249-e250.
     PubMed    
     
     
     
440. FUKASAWA T, Yoshizaki-Ogawa A, Sato S, Yoshizaki A, et al
     The role of B cells in systemic sclerosis.
     J Dermatol. 2024;51:904-913.
     PubMed     Abstract available
     
     
     
441. KOGA H, Teye K, Hamada T, Katsumi T, et al
     A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation.
     J Dermatol. 2024;51:e231-e232.
     PubMed    
     
     
     
442. MATSUMOTO C, Terada N, Harada Y, Takahashi M, et al
     Intractable pemphigus foliaceus after COVID-19 mRNA vaccination.
     J Dermatol. 2024;51:e233-e234.
     PubMed    
     
     
     
443. ZHANG X, Xiao Y, Li X, Wang J, et al
     Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab.
     J Dermatol. 2024;51:1026-1030.
     PubMed     Abstract available
     
     
     
444. LIU Y, Chen L, Xie Y, Deng S, et al
     A case of Bacille Calmette-Guerin-induced generalized lupus vulgaris in a Mendelian susceptibility to mycobacterial disease patient with a novel STAT1 variant.
     J Dermatol. 2024;51:e229-e230.
     PubMed    
     
     
     
445. SOMPOCHPRUETIKUL K, Khongcharoensombat T, Chongpison Y, Rittirongwattana W, et al
     Whey protein and male acne: A double-blind, randomized controlled trial.
     J Dermatol. 2024;51:1022-1025.
     PubMed     Abstract available
     
     
     
446. PIZZICHETTA MA, Corsetti P, Stanganelli I, Ghigliotti G, et al
     More than one shade of pink as a marker of early amelanotic/hypomelanotic melanoma.
     J Dermatol. 2024;51:999-1003.
     PubMed     Abstract available
     
     
     June 2024
447. LIU L, He Y, Hu Q, Sun K, et al
     Vulvar lichen sclerosus in girls and adult females: A single-center retrospective study of 744 patients in China.
     J Dermatol. 2024 Jun 28. doi: 10.1111/1346-8138.17352.
     PubMed     Abstract available
     
     
     
448. DANCE B, Dardare A, Fleming J, Siow SF, et al
     The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.
     J Dermatol. 2024 Jun 24. doi: 10.1111/1346-8138.17276.
     PubMed     Abstract available
     
     
     
449. KIRATIKANON S, Maneenut A, Noppakun N, Kumtornrut C, et al
     Effects of spironolactone on skin biophysical properties in women with acne treated with oral spironolactone.
     J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17333.
     PubMed     Abstract available
     
     
     
450. FAN H, Yan L, Tan Y, Feng J, et al
     Bevacizumab-associated toxic epidermal necrolysis in a patient with liver cancer.
     J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17285.
     PubMed    
     
     
     
451. LIN F, Wang Y, Zheng Y, Hong W, et al
     Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: A retrospective study.
     J Dermatol. 2024 Jun 19. doi: 10.1111/1346-8138.17320.
     PubMed     Abstract available
     
     
     
452. TSAI YY, Chen YJ, Chang LS, Wu CC, et al
     Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted alpha-toxin on filaggrin expression.
     J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17326.
     PubMed     Abstract available
     
     
     
453. ITO K, Akatsuka T, Morimura S, Hamada T, et al
     Primary cutaneous follicle center lymphoma localized on the back for 22 years.
     J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17345.
     PubMed    
     
     
     
454. MITSUYAMA S, Higuchi T, Nabekura T, Wakamatsu K, et al
     Improvement of psoriasis vulgaris in a patient with obesity after bariatric and metabolic surgery: A case letter.
     J Dermatol. 2024 Jun 18. doi: 10.1111/1346-8138.17342.
     PubMed    
     
     
     
455. HA GU, Kim JH, Ha DL, Lee H, et al
     Ultrasonographic evaluation of nail matrix topography for preservative nail surgery of nail unit melanoma.
     J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17340.
     PubMed     Abstract available
     
     
     
456. SUZUKI S, Kamata M, Ito M, Watanabe A, et al
     Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report.
     J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17337.
     PubMed    
     
     
     
457. HIRAI Y, Sakurai J, Yoshida S, Kikuchi T, et al
     Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
     J Dermatol. 2024 Jun 14. doi: 10.1111/1346-8138.17324.
     PubMed     Abstract available
     
     
     
458. KAWAMOTO M, Kawakami Y, Hirai Y, Kubota S, et al
     Disseminated Lomentospora prolificans infection presenting with multiple cutaneous lesions in an immunocompromised host: A case report and literature review.
     J Dermatol. 2024 Jun 12. doi: 10.1111/1346-8138.17322.
     PubMed    
     
     
     
459. KOMATSU S, Kamiya T, Kato J, Uhara H, et al
     A small melanoma of the finger characterized predominantly by nest proliferation and a parallel furrow pattern.
     J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17332.
     PubMed    
     
     
     
460. HEERFORDT IM, Framke E, Windfeld-Mathiasen J, Mogensen M, et al
     Reevaluating the role of interferon-beta in psoriasis pathogenesis: A registry-based self-controlled study.
     J Dermatol. 2024 Jun 11. doi: 10.1111/1346-8138.17338.
     PubMed     Abstract available
     
     
     
461. PAIK K, Kim BR, Youn SW
     Automatic evaluation of Nail Psoriasis Severity Index using deep learning algorithm.
     J Dermatol. 2024 Jun 7. doi: 10.1111/1346-8138.17313.
     PubMed     Abstract available
     
     
     
462. WATABE D, Amano H
     Development of psoriasis during obinutuzumab treatment in a patient with follicular lymphoma.
     J Dermatol. 2024 Jun 7. doi: 10.1111/1346-8138.17317.
     PubMed    
     
     
     
463. YAMASHITA T, Shimizuhira C, Hiwa R, Fukuoka M, et al
     A case of generalized pustular psoriasis following discontinuation of apremilast.
     J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17314.
     PubMed    
     
     
     
464. KUBA-FUYUNO Y, Kido-Nakahara M, Tsuji G, Sakai S, et al
     Proposal of a cutaneous lupus erythematosus-like keratinocyte model in vitro under local conditions using interferon-alpha and Poly I:C and its use in examining the therapeutic effects of tyrosine kinase 2 inhibitor.
     J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17318.
     PubMed    
     
     
     
465. DA ROSA GP, Vide J, Azevedo F, Mota A, et al
     Skin hyperpigmentation heralding an ectopic adrenocorticotropic hormone production.
     J Dermatol. 2024 Jun 3. doi: 10.1111/1346-8138.17323.
     PubMed    
     
     
     
466. PARADISI A, Ciobotariu I, Quattrini L, Ricci F, et al
     Linear atrophoderma of Moulin.
     J Dermatol. 2024;51:e183-e184.
     PubMed    
     
     
     
467. MATSUDA KM, Sugimoto E, Ako Y, Kitamura M, et al
     Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin admini
     J Dermatol. 2024;51:741-751.
     PubMed     Abstract available
     
     
     
468. LIANG S, Fang Y, Zhao Z, Wang B, et al
     Hematological parameters as diagnostic biomarkers for patients with rosacea.
     J Dermatol. 2024;51:791-798.
     PubMed     Abstract available
     
     
     
469. IWASAKI T, Shimoda-Komatsu Y, Ida Y, Shimoyamada H, et al
     A case of chromomycosis due to Cladosporium halotolerans: Successful identification of previously unreported pathogen with a molecular approach.
     J Dermatol. 2024;51:e220-e222.
     PubMed    
     
     
     
470. SCHAFER F, Beltran C, Miranda R, Villaseca MA, et al
     Anetoderma: Unusual clinical presentation of granuloma annulare.
     J Dermatol. 2024;51:e209-e210.
     PubMed    
     
     
     
471. ASAI J, Maruyama A, Katoh N
     Lupus miliaris disseminatus faciei successfully treated with topical adapalene and benzoyl peroxide.
     J Dermatol. 2024;51:e214-e215.
     PubMed    
     
     
     
472. HIOKI C, Oda Y, Moriwaki S, Fukunaga A, et al
     Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.
     J Dermatol. 2024;51:873-877.
     PubMed     Abstract available
     
     
     
473. WADA S, Nakano E, Nakajima M, Kishikawa S, et al
     Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly.
     J Dermatol. 2024;51:e196-e197.
     PubMed    
     
     
     
474. KOIZUMI S, Doi R, Aitake U, Lei X, et al
     Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
     J Dermatol. 2024;51:e203-e204.
     PubMed    
     
     
     
475. NAKATANI K, Noborio R, Nomura Y, Ueki Y, et al
     A case of anti-laminin gamma1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration.
     J Dermatol. 2024;51:869-872.
     PubMed     Abstract available
     
     
     
476. TAKAHAGI S, Matsuo Y, Kanamoto M, Kawamoto I, et al
     Pemphigus vulgaris relapsed with serological shift from single-positive desmoglein-3 antibodies to single-positive desmoglein-1 antibodies.
     J Dermatol. 2024;51:e198-e200.
     PubMed    
     
     
     
477. OMI M, Takeichi T, Ito Y, Yoshikawa T, et al
     Two patients with Hailey-Hailey disease with novel pathogenic ATP2C1 variants suggesting possible genotype/phenotype correlations.
     J Dermatol. 2024;51:e185-e187.
     PubMed    
     
     
     May 2024
478. TERAOKA M, Yonekura S, Takegami T, Murata T, et al
     Effective treatment of topical corticosteroid-resistant dermatitis with delgocitinib in a pediatric patient with Netherton syndrome.
     J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17311.
     PubMed    
     
     
     
479. TAKESHIMA R, Kamata M, Suzuki S, Ito M, et al
     Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not inteleukin-17 inhibitors.
     J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17277.
     PubMed     Abstract available
     
     
     
480. SUGIURA S, Yamamoto B, Fujimoto N
     A case of erosive pustular dermatosis of the scalp with ulcerative colitis successfully treated with upadacitinib.
     J Dermatol. 2024 May 28. doi: 10.1111/1346-8138.17282.
     PubMed    
     
     
     
481. PAPA V, Li Pomi F, Borgia F, Vaccaro M, et al
     Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role.
     J Dermatol. 2024 May 22. doi: 10.1111/1346-8138.17278.
     PubMed     Abstract available
     
     
     
482. AKATSUKA T, Matsuoka A, Norimatsu Y, Morimura S, et al
     A case of IgG4-related disease presenting as skin tumors in the bilateral cheeks.
     J Dermatol. 2024 May 17. doi: 10.1111/1346-8138.17271.
     PubMed    
     
     
     
483. TADA Y, Sugiura Y, Kamishima M, Tanaka Y, et al
     Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.
     J Dermatol. 2024 May 15. doi: 10.1111/1346-8138.17255.
     PubMed     Abstract available
     
     
     
484. NAKANO E, Takahashi A, Ogata D, Namikawa K, et al
     Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan.
     J Dermatol. 2024 May 8. doi: 10.1111/1346-8138.17263.
     PubMed     Abstract available
     
     
     
485. JO SJ, Park CJ, Bang CH, Jeong KH, et al
     Effectiveness of calcipotriol/betamethasone dipropionate aerosol foam in patients with small versus large plaque psoriasis in routine practice in South Korea.
     J Dermatol. 2024 May 8. doi: 10.1111/1346-8138.17253.
     PubMed     Abstract available
     
     
     
486. TAIRA H, Ito Y, Yamamoto T, Koyama A, et al
     Elevated serum vasohibin-1 levels in atopic dermatitis: Implications for disease chronicity.
     J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17259.
     PubMed     Abstract available
     
     
     
487. WAKI Y, Nobeyama Y, Nakagawa H, Asahina A, et al
     High prevalence of dermatophytosis of the feet in acral melanoma of the foot.
     J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17256.
     PubMed     Abstract available
     
     
     
488. AITAKE U, Ishizuki S, Lei X, Izumi T, et al
     Long-term control of giant primary acral melanoma without amputation surgery.
     J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17267.
     PubMed    
     
     
     
489. TAKAYAMA E, Kuwahara S, Yoshioka A, Tateishi C, et al
     Granular C3 dermatosis-A report of two cases and a mini-review of literature.
     J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17257.
     PubMed     Abstract available
     
     
     
490. WADA M, Ota S, Sugawara-Mikami M, Yaguchi T, et al
     Primary cutaneous nocardiosis caused by Nocardia beijingensis in an immunocompetent host in Japan.
     J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17266.
     PubMed    
     
     
     
491. WATANABE K, Otsuki M, Ohara Y, Wakasa T, et al
     White patches due to complete loss of melanocytes in vulvar lichen sclerosis: Concomitant presence of vitiligo or not?
     J Dermatol. 2024 May 6. doi: 10.1111/1346-8138.17265.
     PubMed    
     
     
     
492. SHI Y, Wan S, Song X
     Role of neurogenic inflammation in the pathogenesis of alopecia areata.
     J Dermatol. 2024;51:621-631.
     PubMed     Abstract available
     
     
     
493. GRAM SB, Brusgaard K, Bygum A, Christensen AH, et al
     Plantar keratoderma and curly hair as a diagnostic clue of cardiomyopathy risk.
     J Dermatol. 2024;51:e143-e144.
     PubMed    
     
     
     
494. IM D, Ueda K, Niwa H, Tanaka K, et al
     Low pH condition impairs BP-IgG binding to the basement membrane zone.
     J Dermatol. 2024;51:643-648.
     PubMed     Abstract available
     
     
     
495. FUSHIDA N, Horii M, Fujii K, Mizumaki K, et al
     Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective study.
     J Dermatol. 2024;51:704-713.
     PubMed     Abstract available
     
     
     
496. TAO S, Cao P, Jin M, Suo P, et al
     Integrated analysis of long non-coding RNAs and mRNAs associated with condyloma acuminatum.
     J Dermatol. 2024;51:671-683.
     PubMed     Abstract available
     
     
     
497. CHOI S, Kwon SH, Sim WY, Lew BL, et al
     Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy.
     J Dermatol. 2024;51:684-690.
     PubMed     Abstract available
     
     
     
498. PIZZICHETTA MA, Polesel J, Perrot JL, Rubegni P, et al
     The combination of dermoscopy and reflectance confocal microscopy increases the diagnostic confidence of amelanotic/hypomelanotic lentigo maligna.
     J Dermatol. 2024;51:714-718.
     PubMed     Abstract available
     
     
     
499. MIYAMOTO J, Kawashima Y, Hayakawa M, Fusumae T, et al
     Successful treatment of onychomatricoma with minimally invasive surgical procedures based on its pathogenesis: A case report.
     J Dermatol. 2024;51:719-721.
     PubMed     Abstract available
     
     
     
500. PASCOLINI G, Di Zenzo G, Morani P, Didona B, et al
     Ectoderm-derived findings in Ayme-Gripp syndrome.
     J Dermatol. 2024;51:e162-e163.
     PubMed    
     
     
     
501. SHIMOMURA-ISHIHARA M, Takeichi T, Noda T, Koizumi H, et al
     Natal teeth, hypoplasia of the first toe, and growth retardation in a patient with severe epidermolysis bullosa simplex.
     J Dermatol. 2024;51:e175-e177.
     PubMed    
     
     
     
502. OGURA Y, Kondo S, Suzuki T, Otsuka M, et al
     DiGeorge syndrome presenting with palmoplantar pustules: Comparative analysis of serum IL-22, NETs and IL-8 with usual palmoplantar pustulosis.
     J Dermatol. 2024;51:731-734.
     PubMed     Abstract available
     
     
     
503. MATSUO M, Niwa H, Koga H, Ishii N, et al
     A case of paraneoplastic pemphigus associated with follicular lymphoma positive only for anti-desmoglein 3 antibody.
     J Dermatol. 2024;51:e164-e165.
     PubMed    
     
     
     
504. WAKI Y, Nobeyama Y, Chujo S, Asahina A, et al
     Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange.
     J Dermatol. 2024;51:e149-e150.
     PubMed    
     
     
     
505. WATANABE Y, Nobeyama Y, Asahina A
     A case of postoperative pyoderma gangrenosum on penis caused by patient himself.
     J Dermatol. 2024;51:e154-e155.
     PubMed    
     
     
     
506. MAENG JE, Son SW, Lee SJ, Kim JC, et al
     Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.
     J Dermatol. 2024;51:722-726.
     PubMed     Abstract available
     
     
     April 2024
507. SATO M, Yamamoto T
     Cutaneous manifestations of adult-onset Still's disease: A comparative study between young-onset and elderly-onset groups.
     J Dermatol. 2024 Apr 29. doi: 10.1111/1346-8138.17235.
     PubMed     Abstract available
     
     
     
508. MINAMI Y, Shinkuma S, Yokoyama T, Shinoda S, et al
     A case of generalized pustular psoriasis complicated with SLE successfully treated with spesolimab.
     J Dermatol. 2024 Apr 28. doi: 10.1111/1346-8138.17243.
     PubMed    
     
     
     
509. HIGASHI Y, Imafuku S, Tsuruta N, Murotani K, et al
     Systemic therapy for psoriasis and the risk of cutaneous infections.
     J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17245.
     PubMed     Abstract available
     
     
     
510. SONG WJ, Yoon HS
     Impact of residual skin lesions and previous biologic treatment failure on patient-reported outcomes in patients with psoriasis receiving biologic treatment.
     J Dermatol. 2024 Apr 25. doi: 10.1111/1346-8138.17249.
     PubMed     Abstract available
     
     
     
511. SUGIURA R, Hashimoto T, Ishizuka Y, Okuzawa M, et al
     Matrix metalloproteinase-9 and neutrophil elastase from infiltrating neutrophils with neutrophil extracellular DNA traps in linear IgA bullous dermatosis: A case report.
     J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17244.
     PubMed    
     
     
     
512. TANAKA A, Yuasa A, Kamei K, Nagano M, et al
     Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan.
     J Dermatol. 2024 Apr 22. doi: 10.1111/1346-8138.17234.
     PubMed     Abstract available
     
     
     
513. MINAGAWA A, Koga H, Matsunaga K, Hamada A, et al
     Difference in computer-assistance effects on human doctor accuracy in diagnosing acral and non-acral pigmented skin tumors.
     J Dermatol. 2024 Apr 18. doi: 10.1111/1346-8138.17240.
     PubMed    
     
     
     
514. FUJIOKA K, Kita M, Iwata M, Moriue T, et al
     Multiple cutaneous focal mucinosis in a patient with atopic dermatitis.
     J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17213.
     PubMed    
     
     
     
515. KIM DS, Kim JC, Baek DJ, Kang HY, et al
     Successful repigmentation of hypopigmented scars with micropunch grafting with a skin-seeding technique.
     J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17216.
     PubMed     Abstract available
     
     
     
516. TAKAHASHI-WATANABE M, Fujimura T, Amagai R, Ohuchi K, et al
     Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.
     J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17221.
     PubMed     Abstract available
     
     
     
517. ZHANG L, Jin L, Zhao Y, Cai H, et al
     A case of monoclonal gammopathy of cutaneous significance with multiple organs involvement: Comment on "Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia".
     J Dermatol. 2024 Apr 17. doi: 10.1111/1346-8138.17236.
     PubMed    
     
     
     
518. TAKAHASHI T, Takahashi T, Ikawa T, Terui H, et al
     Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
     J Dermatol. 2024 Apr 15. doi: 10.1111/1346-8138.17233.
     PubMed     Abstract available
     
     
     
519. BABA A, Yamada K, Kanekura T
     Cutaneous adverse events following COVID-19 vaccination: A case series of 30 Japanese patients and a review of 93 Japanese studies.
     J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17188.
     PubMed     Abstract available
     
     
     
520. LIU Q, Su H, Hong C, Han J, et al
     Toxic epidermal necrolysis complicated with primary cutaneous aspergillosis: A report of four cases.
     J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17226.
     PubMed     Abstract available
     
     
     
521. HAYAKAWA K, Irisawa R, Umefune R, Mae K, et al
     Marked effect of larotrectinib on primary cutaneous secretory carcinoma: A case report.
     J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17218.
     PubMed    
     
     
     
522. SITTIWATTANAWONG P, Kantikosum K, Charoenchaipiyakul K, Pootongkam S, et al
     In-vivo and ex-vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions.
     J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17207.
     PubMed     Abstract available
     
     
     
523. SUGIURA R, Hashimoto T, Okuno S, Satoh T, et al
     Expression of phosphorylated-Janus kinase 1 and IL-4Ralpha by dermal basophils and epidermal keratinocytes in atopic dermatitis-associated prurigo nodules: A case report.
     J Dermatol. 2024 Apr 11. doi: 10.1111/1346-8138.17229.
     PubMed    
     
     
     
524. HANAMI Y, Yamamoto T
     Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
     J Dermatol. 2024 Apr 8. doi: 10.1111/1346-8138.17199.
     PubMed    
     
     
     
525. UHARA H, Kiyohara Y, Isei T, Nagase K, et al
     Safety and effectiveness of avelumab in patients with Merkel cell carcinoma in general clinical practice in Japan: Post-marketing surveillance.
     J Dermatol. 2024;51:475-483.
     PubMed     Abstract available
     
     
     
526. LIM S, Sidky L, Eliott E, Cobos G, et al
     A gyrate pattern of discoid lupus erythematosus.
     J Dermatol. 2024;51:e106-e107.
     PubMed    
     
     
     
527. HAMADA R, Funasaka Y, Saeki H, Serizawa N, et al
     Dietary habits in adult Japanese patients with vitiligo.
     J Dermatol. 2024;51:491-508.
     PubMed     Abstract available
     
     
     
528. PAN X, Dong Z
     Yellow urticaria following plasma transfusion.
     J Dermatol. 2024;51:e108-e109.
     PubMed    
     
     
     
529. KIM KH, Kwon SH, Sim WY, Lew BL, et al
     Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study.
     J Dermatol. 2024;51:552-557.
     PubMed     Abstract available
     
     
     
530. TSUNEMI Y, Otsuka A, Nonaka Y
     Receipt survey of prescription continuation rates for patients with onychomycosis and web-based survey of dermatologists on prescribing policies for onychomycosis therapeutics.
     J Dermatol. 2024;51:526-531.
     PubMed     Abstract available
     
     
     
531. FAJUYIGBE D, Sewraj P, Connetable S, Molamodi K, et al
     Weekly hair washing: The recommended solution for women with afro-textured hair to alleviate dandruff and scalp discomfort.
     J Dermatol. 2024;51:518-525.
     PubMed     Abstract available
     
     
     
532. CHATPROEDPRAI S, Tiasiri N, Chantawarangkul K, Wananukul S, et al
     Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
     J Dermatol. 2024;51:509-517.
     PubMed     Abstract available
     
     
     
533. AO S, Huang G, Tang X, Zhu Z, et al
     Anti-immunoglobulin E provides an additional therapy to conventional steroids for Kimura's disease.
     J Dermatol. 2024;51:602-606.
     PubMed     Abstract available
     
     
     
534. SUN X, Zhang J, Yang Q, Lin J, et al
     Treatment of epidermolysis bullosa simplex with dupilumab.
     J Dermatol. 2024;51:e131-e132.
     PubMed    
     
     
     
535. SAKAMOTO K, Fujihiro M, Sakamoto A, Yamada C, et al
     A case of nonpigmented fixed-drug eruption with eosinophilic intraepidermal vesicle formation.
     J Dermatol. 2024;51:e120-e122.
     PubMed    
     
     
     
536. USUI-TANIGUCHI M, Kawakami Y, Toi Y, Kaji T, et al
     Pruritic folliculitis of pregnancy with granular deposition of immunoglobulin G along the basement membrane zone.
     J Dermatol. 2024;51:e125-e126.
     PubMed    
     
     
     
537. LEE SG, Kim SC, Kim JH
     Risk factors of rituximab-induced thrombocytopenia in patients with autoimmune bullous diseases.
     J Dermatol. 2024;51:597-601.
     PubMed     Abstract available
     
     
     March 2024
538. YOKOTA K, Takenouchi T, Fujisawa Y, Fukushima S, et al
     Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma.
     J Dermatol. 2024 Mar 26. doi: 10.1111/1346-8138.17002.
     PubMed     Abstract available
     
     
     
539. IKUMI N, Hayama K, Kitamura N, Terui T, et al
     Higher prevalence of nail psoriasis in patients with psoriatic arthritis receiving biologic therapy: A single center cross sectional study.
     J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17196.
     PubMed    
     
     
     
540. FUJIMOTO A, Hayashi R, Iguchi S, Abe R, et al
     Can dermatologists reach their full potential in teledermatology? A validation study of diagnostic performance of skin diseases in live video conferencing teledermatology.
     J Dermatol. 2024 Mar 20. doi: 10.1111/1346-8138.17197.
     PubMed     Abstract available
     
     
     
541. XIE L, Lopes Almeida Gomes L, Stone CJ, Faden DF, et al
     An update on clinical trials for cutaneous lupus erythematosus.
     J Dermatol. 2024 Mar 15. doi: 10.1111/1346-8138.17161.
     PubMed     Abstract available
     
     
     
542. TEBOUL A, Arnaud L, Chasset F
     Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
     J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17177.
     PubMed     Abstract available
     
     
     
543. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
     Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study.
     J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17186.
     PubMed     Abstract available
     
     
     
544. HEMMI A, Okamura K, Nikaido M, Saito T, et al
     Post-COVID-19 vaccination diffuse cutaneous sarcoidosis.
     J Dermatol. 2024 Mar 14. doi: 10.1111/1346-8138.17194.
     PubMed    
     
     
     
545. CHIU YJ, Li CY, Wang TH, Ma H, et al
     Comparative transcriptomic analysis reveals differences in gene expression and regulatory pathways between nonacral and acral melanoma in Asian individuals.
     J Dermatol. 2024 Mar 12. doi: 10.1111/1346-8138.17187.
     PubMed     Abstract available
     
     
     
546. HASEGAWA M, Chasset F, Chong BF, Fiorentino DF, et al
     International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
     J Dermatol. 2024 Mar 7. doi: 10.1111/1346-8138.17153.
     PubMed     Abstract available
     
     
     
547. TAKADA M, Kikuchi N, Yamamoto T
     Umbilical psoriasis is not relevant to psoriatic arthritis.
     J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17189.
     PubMed     Abstract available
     
     
     
548. TAKAYAMA E, Takai T, Fujimoto M, Yoshioka A, et al
     Bowen disease with sebaceous differentiation arising from clonal seborrheic keratosis.
     J Dermatol. 2024 Mar 5. doi: 10.1111/1346-8138.17180.
     PubMed     Abstract available
     
     
     
549. KITAYAMA S, Katsuumi K, Takatsuka S, Shimizu T, et al
     Clinical features of skin metastasis from breast cancer: A retrospective observational study in Japan.
     J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17176.
     PubMed    
     
     
     
550. UCHIYAMA A, Kosaka K, Ishikawa M, Inoue Y, et al
     Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.
     J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17173.
     PubMed     Abstract available
     
     
     
551. OYA K, Nakamura Y, Shen LT, Ishizuki S, et al
     Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.
     J Dermatol. 2024 Mar 3. doi: 10.1111/1346-8138.17183.
     PubMed     Abstract available
     
     
     
552. KIRCHLER CA, Fritz A, Spiegelfeld C, Mullegger RR, et al
     19-month follow-up survey on women with atopic eruption of pregnancy postpartum: An encouraging outlook.
     J Dermatol. 2024;51:467-469.
     PubMed    
     
     
     
553. ODAWARA M, Mezaki M, Yoshimura T, Takaoka A, et al
     Epidermal turnover and iron metabolism in senile lentigo.
     J Dermatol. 2024;51:453-457.
     PubMed     Abstract available
     
     
     
554. HE MJ, Wang YJ, Ran DL, Fu DS, et al
     Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study.
     J Dermatol. 2024;51:403-408.
     PubMed     Abstract available
     
     
     
555. KWON IJ, Kim SE, Kim SC, Lee SE, et al
     Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series.
     J Dermatol. 2024;51:441-447.
     PubMed     Abstract available
     
     
     
556. YU DA, Kim SR, Cho SI, Kwon O, et al
     Endocrine and metabolic comorbidities in primary cicatricial alopecia: A nationwide population-based study.
     J Dermatol. 2024;51:429-440.
     PubMed     Abstract available
     
     
     
557. RAO L, Yang M, Chen H, Feng YY, et al
     Monkeypox 2023 in China: Dermatologist in the frontline with dermoscopic and reflectance confocal microscopy findings.
     J Dermatol. 2024;51:e81-e82.
     PubMed    
     
     
     
558. ZHOU Y, Xiao Y, Wang Y, Li W, et al
     Refractory atypical IgA pemphigus successfully treated with apremilast.
     J Dermatol. 2024;51:e86-e87.
     PubMed    
     
     
     
559. AKASAKA E, Rokunohe D, Nakano H, Yamatani S, et al
     A case of adult-onset localized recessive dystrophic epidermolysis bullosa, harboring the novel COL7A1 mutation p.G2754E and the previously reported mutation p.R1763.
     J Dermatol. 2024;51:e74-e76.
     PubMed    
     
     
     
560. SUGIOKA K, Kondo M, Yamanaka K
     Elephantiasis verrucous lesions on psoriatic plaque improved with anti-IL-23p19 antibody therapy.
     J Dermatol. 2024;51:e77-e78.
     PubMed    
     
     
     
561. KOBAYASHI A, Terui H, Takahashi T, Mizuashi M, et al
     A case of lymphangiectatic variant of giant pilomatricoma with bullous appearance: evaluation through magnetic resonance imaging.
     J Dermatol. 2024;51:e79-e80.
     PubMed    
     
     
     
562. TSUJI H, Ichiki N, Niwa H, Iwata H, et al
     Bullous pemphigoid following hand, foot, and mouth disease.
     J Dermatol. 2024;51:e68-e69.
     PubMed    
     
     
     February 2024
563. HASHIZUME H, Ishikawa Y, Hata A
     Increased Demodex mites after dupilumab therapy in facial skin: A case report.
     J Dermatol. 2024 Feb 29. doi: 10.1111/1346-8138.17150.
     PubMed    
     
     
     
564. KOJIMA R, Miyake K, Shinohara R, Kushima M, et al
     Association between filaggrin gene mutations and the clinical features of molluscum contagiosum: The Yamanashi Adjunct Study of the Japan Environment and Children's Study.
     J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17157.
     PubMed     Abstract available
     
     
     
565. KAMEDA E, Matsuzawa T, Togawa Y, Hashimoto R, et al
     Amelanotic melanoma in oculocutaneous albinism type 4 detected using violet-light dermoscopy.
     J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17164.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.